IKEDA Hiroaki 池田裕明

Researcher Number	40374673
Other IDs
External Links
Affiliation (Current)	2025: 長崎大学, 医歯薬学総合研究科(医学系), 教授
Affiliation (based on the past Project Information) *help	2016 – 2025: 長崎大学, 医歯薬学総合研究科(医学系), 教授 2014 – 2015: 三重大学, 医学(系)研究科(研究院), 教授 2013: 三重大学, 医学(系)研究科(研究院), 准教授 2009 – 2012: Mie University, 大学院・医学系研究科, 准教授 2007: Mie University, Department of Cancer Vaccine, Associate professor 2006: Mie University, 大学院・医学系研究科, 助教授 2005 – 2006: 北海道大学, 遺伝子病制御研究所, 助教授
Review Section/Research Field	Principal Investigator Basic Section 55010:General surgery and pediatric surgery-related / General surgery / Medium-sized Section 53:Organ-based internal medicine and related fields / Medium-sized Section 55:Surgery of the organs maintaining homeostasis and related fields / Thoracic surgery Except Principal Investigator Basic Section 55010:General surgery and pediatric surgery-related / Basic Section 55020:Digestive surgery-related / Basic Section 47060:Clinical pharmacy-related / Basic Section 55040:Respiratory surgery-related / General surgery / Hematology / Thoracic surgery
Keywords	Principal Investigator がん免疫療法 / siRNA / 非自己細胞 / がん / 遺伝子治療 / 腫瘍不均一性 / MHC / TCR / 細胞療法 / GITR … More / 免疫学 / 癌 / T細胞輸注療法 / 制御性T細胞 / T細胞療法 / 免疫療法 / デザイナー細胞 / インターフェロン / バイスタンダー効果 / 腫瘍 / 移植 / がん免疫編集 / 免疫抑制 / 個別化治療 / 免疫抑制機構 / ネオアンチゲン / 個別化医療 / ゲノム編集 / Reeulatory T cells / Antigen epitope / Antigen presentation / Immunoediting / Immunosurveillance / Immunology / Oncology / 消化器外科学 / 呼吸器外科学 / 抗原エピトープ / 抗原提示 / イムノエディティング / 免疫監視機構 / 腫瘍学 / 生存性 / キメラ抗原受容体 / T細胞受容体 / 免疫記憶 / マルチファンクション性 / T細胞 / siTCRベクター / siT+ AV3CRベクター / 遺伝子療法 / T細胞移入療法 / T細胞マルチファンクション性 / 抗腫瘍免疫 / GITRL-Fc / GITRL … More Except Principal Investigator T細胞 / 腫瘍免疫 / がん免疫 / 細胞シート / NY-ESO-1 / 腫瘍不均一性 / CAR-T / リソソーム / PD-L1 / EGFR / PROTAC / ユビキチンリガーゼ / 腫瘍抑制 / 免疫逃避 / デザイナー細胞 / 移植療法 / MHC / 移植医療 / 免疫回避 / セルバンキング / 他家移植 / 骨格筋芽細胞 / 免疫原性 / ユニバーサル骨格筋芽細胞シート / 再生医療等製品 / 十二指腸ESD後穿孔 / 筋芽細胞シート / 他家細胞移植 / 再生医療 / 筋芽細胞 / 細胞輸注療法 / 細胞傷害性T細胞 / 腫瘍殺傷 / ワクチン / キラーT細胞 / 抗原欠損バリアント / 養子免疫療法 / NK細胞 / IRFファミリー / CD47 / ステルスT細胞 / HLA-E / MHC Class I / T細胞輸注療法 / 移植・再生医療 / MHC分子 / ゲノム編集 / 拒絶回避 / 肝移植 / 細胞性拒絶 / 肝細胞 / 組織適合性抗原 / ＧＶＨＤ / Ｔ細胞受容体遺伝子改変 / 腫瘍特異的遺伝子改変免疫細胞 / 遺伝子改変リンパ球 / 遺伝子改変細胞 / 移植片対腫瘍効果 / 造血幹細胞移植 / 移植片対宿主病 / 腫瘍特異的リンパ球 / ドナーリンパ球輸注 / 移植後腫瘍再発 / 造血細胞移植 / adjuvant / immuno-therapy / cancer vaccine / advanced cancer / 免疫誘導療法 / 遺伝子診断 / 癌抗原 / 難治癌 / 自然免疫活性化アジュバント / 自然免疫活性化アジュバン / 免疫療法 / 癌ワクチン / 進行再発癌 Less

Identification of novel ubiquitin ligases for cancer-related protein degradation inducers.
- Principal Investigator
  
  金子雅幸
- Project Period (FY)
  2025 – 2027
- Research Category
  
  Grant-in-Aid for Scientific Research (B)
- Review Section
  
  Basic Section 47060:Clinical pharmacy-related
- Research Institution
  Nagasaki University
フェロトーシス誘導を用いて腫瘍不均一性を克服する固形癌に有効なCAR-T療法の開発
- Principal Investigator
  
  安井潔
- Project Period (FY)
  2025 – 2027
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Review Section
  
  Basic Section 55010:General surgery and pediatric surgery-related
- Research Institution
  Nagasaki University
T cell therapy that overcome tumor heterogeneity by expansion of T cell repertoire and immune-related cell death effect.Principal Investigator
- Principal Investigator
  
  池田裕明
- Project Period (FY)
  2024 – 2026
- Research Category
  
  Grant-in-Aid for Scientific Research (B)
- Review Section
  
  Basic Section 55010:General surgery and pediatric surgery-related
- Research Institution
  Nagasaki University
Development of a novel cancer immunotherapy utilizing a new technology that integrates spatial information and gene expression data of T cells within tumors.
- Principal Investigator
  
  村岡大輔
- Project Period (FY)
  2024 – 2026
- Research Category
  
  Grant-in-Aid for Scientific Research (B)
- Review Section
  
  Basic Section 55040:Respiratory surgery-related
- Research Institution
  Aichi Cancer Center Research Institute
分泌タンパク質SCGB3A1による新規腫瘍抑制機構の解明
- Principal Investigator
  
  米田光宏
- Project Period (FY)
  2024 – 2026
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Review Section
  
  Basic Section 55010:General surgery and pediatric surgery-related
- Research Institution
  Nagasaki University
抗原性を消失させたユニバーサルヒト骨格筋芽細胞のセルバンキングの構築に関する研究
- Principal Investigator
  
  丸屋安広
- Project Period (FY)
  2022 – 2024
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Review Section
  
  Basic Section 55010:General surgery and pediatric surgery-related
- Research Institution
  Nagasaki University
免疫逃避機構を付与したデザイナー細胞を用いた新規移植療法の開発
- Principal Investigator
  
  安井潔
- Project Period (FY)
  2022 – 2024
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Review Section
  
  Basic Section 55020:Digestive surgery-related
- Research Institution
  Nagasaki University
バイスタンダー効果を増強する新規化合物による腫瘍不均一性を克服するがん免疫療法Principal Investigator
- Principal Investigator
  
  池田裕明
- Project Period (FY)
  2022 – 2024
- Research Category
  
  Grant-in-Aid for Challenging Research (Exploratory)
- Review Section
  
  Medium-sized Section 53:Organ-based internal medicine and related fields
- Research Institution
  Nagasaki University
Development of Novel Adoptive Cell Therapy for Tumors Containing antigen loss variants cells
- Principal Investigator
  
  Muraoka Daisuke
- Project Period (FY)
  2021 – 2023
- Research Category
  
  Grant-in-Aid for Scientific Research (B)
- Review Section
  
  Basic Section 55020:Digestive surgery-related
- Research Institution
  Aichi Cancer Center Research Institute
Development of immune cell therapy of refractory tumor utilizing allogeneic designer cellsPrincipal Investigator
- Principal Investigator
  
  Ikeda Hiroaki
- Project Period (FY)
  2021 – 2023
- Research Category
  
  Grant-in-Aid for Scientific Research (B)
- Review Section
  
  Basic Section 55010:General surgery and pediatric surgery-related
- Research Institution
  Nagasaki University
Development of effective T cell therapy by stealth technique and regulation of IRF expression
- Principal Investigator
  
  Yasui Kiyoshi
- Project Period (FY)
  2019 – 2021
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Review Section
  
  Basic Section 55010:General surgery and pediatric surgery-related
- Research Institution
  Nagasaki University
Personalized cancer immunotherapy of gastrointestinal tumors based on identification of neoantigens and reverting of immunosuppressionPrincipal Investigator
- Principal Investigator
  
  IKEDA Hiroaki
- Project Period (FY)
  2018 – 2020
- Research Category
  
  Grant-in-Aid for Challenging Research (Exploratory)
- Review Section
  
  Medium-sized Section 55:Surgery of the organs maintaining homeostasis and related fields
- Research Institution
  Nagasaki University
Development of cell therapy for patients with tumors utilizing allogeneic stealth T cellsPrincipal Investigator
- Principal Investigator
  
  IKEDA Hiroaki
- Project Period (FY)
  2018 – 2020
- Research Category
  
  Grant-in-Aid for Scientific Research (B)
- Review Section
  
  Basic Section 55010:General surgery and pediatric surgery-related
- Research Institution
  Nagasaki University
Development of preclinical models of donor-derived gene-modified lymphocyte infusion for tumor-relapse after allogeneic hematopoietic cell transplantation and evaluation of efficacy and safety
- Principal Investigator
  
  TAWARA Isao
- Project Period (FY)
  2017 – 2019
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Hematology
- Research Institution
  Mie University
Induction of immune tolerance by transplantation of hepatocyte sheet that lost antigenicity
- Principal Investigator
  
  TAKATSUKI Mitsuhisa
- Project Period (FY)
  2017 – 2019
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  General surgery
- Research Institution
  Nagasaki University
Analysis of elimination of non-self and development of Stealth T cells aiming generalized antigen-specific adoptive T cell therapyPrincipal Investigator
- Principal Investigator
  
  IKEDA Hiroaki
- Project Period (FY)
  2015 – 2017
- Research Category
  
  Grant-in-Aid for Scientific Research (B)
- Research Field
  
  General surgery
- Research Institution
  Nagasaki University
  Mie University
Identification of factors that determine the fate of functional T cells in vivo and development of effective TCR gene-modified T cell therapyPrincipal Investigator
- Principal Investigator
  
  IKEDA Hiroaki
- Project Period (FY)
  2012 – 2014
- Research Category
  
  Grant-in-Aid for Scientific Research (B)
- Research Field
  
  General surgery
- Research Institution
  Mie University
Development of a novel cellular vaccine of GITRL-Fc expressing tumor cells for treatment of patients with advanced malignancyPrincipal Investigator
- Principal Investigator
  
  IKEDA Hiroaki
- Project Period (FY)
  2009 – 2011
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  General surgery
- Research Institution
  Mie University
Analysis of cancer immunceditine in antigen presentation-related molecules and development of treatment to inhibit escape mechanisms of cancerPrincipal Investigator
- Principal Investigator
  
  IKEDA Hiroaki
- Project Period (FY)
  2006 – 2007
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Thoracic surgery
- Research Institution
  Mie University
Phase I clinical trial of cancer vaccine using adjuvant for activation of immunity
- Principal Investigator
  
  MIYAMOTO Masaki, MORIKAWA Toshiaki
- Project Period (FY)
  2005 – 2006
- Research Category
  
  Grant-in-Aid for Scientific Research (B)
- Research Field
  
  Thoracic surgery
- Research Institution
  HOKKAIDO UNIVERSITY
  Jikei University School of Medicine

[Book] 新臨床腫瘍学(改訂第7版)2024
- Author(s)
  池田裕明、安藤雄一、春名健伍、吉田健一、河津正人、櫻井宏明、曽和喜広、高橋暁子、丸山玲緒、山本雄介、早川芳弘、樋田京子、平尾敦、野口耕司、本橋ほずみ、坂井和子、岡本渉、富田秀太、松本雅記、足立雄太　他
- Total Pages
  767
- Publisher
  南江堂
- ISBN
  9784524204267
- Data Source
  KAKENHI-PROJECT-21H02990
[Book] 新臨床腫瘍学(改訂第7版)2024
- Author(s)
  池田裕明、安藤雄一、春名健伍、吉田健一、河津正人、櫻井宏明、曽和喜広、高橋暁子、丸山玲緒、山本雄介、早川芳弘、樋田京子、平尾敦、野口耕司、本橋ほずみ、坂井和子、岡本渉、富田秀太、松本雅記、足立雄太　他
- Total Pages
  767
- Publisher
  南江堂
- ISBN
  9784524204267
- Data Source
  KAKENHI-PROJECT-22K19532
[Book] がん免疫療法ガイドライン第３版2023
- Author(s)
  池田裕明　他
- Total Pages
  249
- Publisher
  金原出版株式会社
- ISBN
  9784307102124
- Data Source
  KAKENHI-PROJECT-21H02990
[Book] がん免疫療法ガイドライン第3版2023
- Author(s)
  池田裕明他
- Total Pages
  249
- Publisher
  金原出版株式会社
- ISBN
  9784307102124
- Data Source
  KAKENHI-PROJECT-22K19532
[Book] 遺伝子治療開発研究ハンドブック第2版2023
- Author(s)
  池田裕明、藤堂具紀、金田安史、島田隆、小澤敬也、内田直也、水口裕之、中西真人、中神啓徳、森下竜一、山本卓、三谷幸之介、谷憲三朗、下剛典、小比賀聡、坂野文香、阿部奈保子、阿部洋、三浦裕、西山伸宏他
- Total Pages
  772
- Publisher
  エヌ・ティー・エス
- ISBN
  9784860438401
- Data Source
  KAKENHI-PROJECT-22K19532
[Book] 遺伝子治療開発研究ハンドブック第2版2023
- Author(s)
  池田裕明、藤堂具紀、金田安史、島田隆、小澤敬也、内田直也、水口裕之、中西真人、中神啓徳、森下竜一、山本卓、三谷幸之介、谷憲三朗、下剛典、小比賀聡、坂野文香、阿部奈保子、阿部洋、三浦裕、西山伸宏、他
- Total Pages
  772
- Publisher
  エヌ・ティー・エス
- ISBN
  9784860438401
- Data Source
  KAKENHI-PROJECT-21H02990
[Book] がん免疫療法最前線2023
- Author(s)
  池田裕明、鳥越俊彦、佐藤精一、高岡晃教、上羽悟史、金関貴幸、石井絢菜、本橋新一郎、小山正平、西川博嘉、北村秀光、垣見和宏、天野瑶子、渡邊智文、冨樫庸介、吉村清、西田充香子、鵜殿平一郎、岩井佳子、飯田雄一他
- Total Pages
  61
- Publisher
  日本医学出版
- ISBN
  9784865770605
- Data Source
  KAKENHI-PROJECT-22K19532
[Book] がん免疫療法最前線2023
- Author(s)
  池田裕明、鳥越俊彦、佐藤精一、高岡晃教、上羽悟史、金関貴幸、石井絢菜、本橋新一郎、小山正平、西川博嘉、北村秀光、垣見和宏、天野瑶子、渡邊智文、冨樫庸介、吉村清、西田充香子、鵜殿平一郎、岩井佳子、飯田雄一、他
- Total Pages
  61
- Publisher
  日本医学出版
- ISBN
  9784865770605
- Data Source
  KAKENHI-PROJECT-21H02990
[Book] 必修!腫瘍免疫学:がんに対する宿主免疫応答2022
- Author(s)
  池田裕明
- Total Pages
  8
- Publisher
  金原出版株式会社
- ISBN
  9784307102087
- Data Source
  KAKENHI-PROJECT-22K19532
[Book] 腫瘍内科　特集　がん免疫療法の進歩：遺伝子改変免疫細胞療法の進展2022
- Author(s)
  池田裕明
- Total Pages
  8
- Publisher
  科学評論社
- Data Source
  KAKENHI-PROJECT-21H02990
[Book] 医学のあゆみ 281(5) :遺伝子導入T細胞による養子免疫療法2022
- Author(s)
  池田裕明
- Total Pages
  6
- Publisher
  医歯薬出版株式会社
- Data Source
  KAKENHI-PROJECT-22K19532
[Book] 必修！腫瘍免疫学：がんに対する宿主免疫応答2022
- Author(s)
  池田裕明
- Total Pages
  8
- Publisher
  金原出版株式会社
- ISBN
  9784307102087
- Data Source
  KAKENHI-PROJECT-21H02990
[Book] 医学のあゆみ 281(5) ：遺伝子導入T細胞による養子免疫療法2022
- Author(s)
  池田裕明
- Total Pages
  6
- Publisher
  医歯薬出版株式会社
- Data Source
  KAKENHI-PROJECT-21H02990
[Book] BIO Clinica CAR-T細胞療法の基礎と臨床：固形がんを標的としたCAR-T細胞療法2021
- Author(s)
  安井潔、池田裕明
- Total Pages
  5
- Publisher
  北隆舘
- Data Source
  KAKENHI-PROJECT-21H02990
[Book] 新臨床腫瘍学（改訂第６版）：がんと免疫2021
- Author(s)
  池田裕明
- Total Pages
  7
- Publisher
  南江堂
- ISBN
  9784524227396
- Data Source
  KAKENHI-PROJECT-21H02990
[Book] 週刊　医学のあゆみ　遺伝子改変T細胞療法2020
- Author(s)
  池田裕明
- Total Pages
  6
- Publisher
  医歯薬出版株式会社
- Data Source
  KAKENHI-PROJECT-18K19584
[Book] 実験医学非自己のリンパ球を用いたがん免疫療法の開発2020
- Author(s)
  池田裕明
- Total Pages
  7
- Publisher
  羊土社
- Data Source
  KAKENHI-PROJECT-18K19584
[Book] 週刊　医学のあゆみ　遺伝子改変T細胞療法2020
- Author(s)
  池田裕明
- Total Pages
  6
- Publisher
  医歯薬出版株式会社
- Data Source
  KAKENHI-PROJECT-18H02872
[Book] 腫瘍内科がん免疫における新規治療アプローチ2)TCR-T細胞によるがん治療2020
- Author(s)
  安井潔、池田裕明
- Total Pages
  8
- Publisher
  科学評論社
- Data Source
  KAKENHI-PROJECT-18K19584
[Book] 実験医学　非自己のリンパ球を用いたがん免疫療法の開発2020
- Author(s)
  池田裕明
- Total Pages
  7
- Publisher
  羊土社
- Data Source
  KAKENHI-PROJECT-18H02872
[Book] 腫瘍内科　がん免疫における新規治療アプローチ２）TCR-T細胞によるがん治療2020
- Author(s)
  安井潔、池田裕明
- Total Pages
  8
- Publisher
  科学評論社
- Data Source
  KAKENHI-PROJECT-18H02872
[Book] BIO Clinica 免疫チェックポイント阻害剤の衝撃と、がん免疫療法のさらなる発展2019
- Author(s)
  池田裕明
- Total Pages
  7
- Publisher
  北隆館
- ISBN
- Data Source
  KAKENHI-PROJECT-18H02872
[Book] 実験医学　細胞輸注療法(TIL療法、TCR療法)2019
- Author(s)
  池田裕明
- Total Pages
  7
- Publisher
  羊土社
- ISBN
  9784758103817
- Data Source
  KAKENHI-PROJECT-18H02872
[Book] がん生物学がん抗原2019
- Author(s)
  池田裕明
- Total Pages
  11
- Publisher
  羊土社
- ISBN
- Data Source
  KAKENHI-PROJECT-18K19584
[Book] 内科学書第9版　感染、免疫、アレルギー２免疫異常2019
- Author(s)
  池田裕明
- Total Pages
  9
- Publisher
  中山書店
- ISBN
  9784521747491
- Data Source
  KAKENHI-PROJECT-18H02872
[Book] 臨床血液造血器腫瘍および固形腫瘍に対するTCR遺伝子導入リンパ球輸注療法の開発2019
- Author(s)
  池田裕明
- Total Pages
  7
- Publisher
  日本血液学会
- ISBN
- Data Source
  KAKENHI-PROJECT-18K19584
[Book] 医学と薬学 TCR遺伝子改変細胞治療2019
- Author(s)
  池田裕明
- Total Pages
  8
- Publisher
  自然科学社
- ISBN
  9784909260185
- Data Source
  KAKENHI-PROJECT-18K19584
[Book] BIO CLINICA がん免疫療法の最前線2019
- Author(s)
  池田裕明
- Total Pages
  3
- Publisher
  北隆館
- ISBN
- Data Source
  KAKENHI-PROJECT-18H02872
[Book] 医学と薬学　TCR遺伝子改変細胞治療2019
- Author(s)
  池田裕明
- Total Pages
  8
- Publisher
  自然科学社
- ISBN
  9784909260185
- Data Source
  KAKENHI-PROJECT-18H02872
[Book] 臨床血液　造血器腫瘍および固形腫瘍に対するTCR遺伝子導入リンパ球輸注療法の開発2019
- Author(s)
  池田裕明
- Total Pages
  7
- Publisher
  日本血液学会
- ISBN
- Data Source
  KAKENHI-PROJECT-18H02872
[Book] がん生物学　がん抗原2019
- Author(s)
  池田裕明
- Total Pages
  11
- Publisher
  羊土社
- ISBN
  9784758120968
- Data Source
  KAKENHI-PROJECT-18H02872
[Book] 内科学書第9版感染、免疫、アレルギー2免疫異常2019
- Author(s)
  池田裕明
- Total Pages
  9
- Publisher
  中山書店
- ISBN
  9784521747491
- Data Source
  KAKENHI-PROJECT-18K19584
[Book] BIO Clinica 免疫チェックポイント阻害剤の衝撃と、がん免疫療法のさらなる発展2019
- Author(s)
  池田裕明
- Total Pages
  7
- Publisher
  北隆館
- ISBN
- Data Source
  KAKENHI-PROJECT-18K19584
[Book] BIO CLINICA がん免疫療法の最前線2019
- Author(s)
  池田裕明
- Total Pages
  3
- Publisher
  北隆館
- ISBN
- Data Source
  KAKENHI-PROJECT-18K19584
[Book] 実験医学細胞輸注療法(TIL療法、TCR療法)2019
- Author(s)
  池田裕明
- Total Pages
  7
- Publisher
  羊土社
- ISBN
  9784758103817
- Data Source
  KAKENHI-PROJECT-18K19584
[Book] 炎症と免疫　T細胞を用いた養子免疫療養（TIL, TCR/CAR遺伝子導入T細胞）2018
- Author(s)
  池田裕明
- Total Pages
  6
- Publisher
  先端医学社
- ISBN
- Data Source
  KAKENHI-PROJECT-18H02872
[Book] 固形がんに対するT細胞輸注療法（Ｔ細胞輸注法シリーズ4）、がん免疫療法2018
- Author(s)
  池田裕明
- Total Pages
  84
- Publisher
  メディカルビュー社
- Data Source
  KAKENHI-PROJECT-15H04918
[Book] 別冊・医学のあゆみ　がん免疫療法の躍進2018
- Author(s)
  池田裕明
- Total Pages
  5
- Publisher
  医歯薬出版株式会社
- ISBN
- Data Source
  KAKENHI-PROJECT-18H02872
[Book] 別冊・医学のあゆみがん免疫療法の躍進2018
- Author(s)
  池田裕明
- Total Pages
  5
- Publisher
  医歯薬出版株式会社
- ISBN
- Data Source
  KAKENHI-PROJECT-18K19584
[Book] 腫瘍内科細胞輸注療法の現状と展望2018
- Author(s)
  池田裕明
- Total Pages
  6
- Publisher
  科学評論社
- ISBN
- Data Source
  KAKENHI-PROJECT-18K19584
[Book] ネオ抗原に対するT細胞輸注療法（Ｔ細胞輸注法シリーズ３）、がん免疫療法2018
- Author(s)
  池田裕明
- Total Pages
  84
- Publisher
  メディカルビュー社
- Data Source
  KAKENHI-PROJECT-15H04918
[Book] 腫瘍内科　細胞輸注療法の現状と展望2018
- Author(s)
  池田裕明
- Total Pages
  6
- Publisher
  科学評論社
- ISBN
- Data Source
  KAKENHI-PROJECT-18H02872
[Book] 炎症と免疫 T細胞を用いた養子免疫療養(TIL, TCR/CAR遺伝子導入T細胞)2018
- Author(s)
  池田裕明
- Total Pages
  6
- Publisher
  先端医学社
- ISBN
- Data Source
  KAKENHI-PROJECT-18K19584
[Book] TCR遺伝子改変T細胞療法、最新医学2018
- Author(s)
  池田裕明
- Total Pages
  146
- Publisher
  最新医学社
- Data Source
  KAKENHI-PROJECT-15H04918
[Book] T細胞輸注療法の歴史　がん免疫療法2017
- Author(s)
  池田裕明
- Publisher
  メディカルレビュー社
- Data Source
  KAKENHI-PROJECT-15H04918
[Book] Ｔ細胞受容体遺伝子改変技術を用いたがん治療2017
- Author(s)
  池田裕明
- Total Pages
  79
- Publisher
  癌と化学療法社
- Data Source
  KAKENHI-PROJECT-15H04918
[Book] CAR-T細胞療法の進展（Ｔ細胞輸注法シリーズ２）、がん免疫療法2017
- Author(s)
  池田裕明
- Total Pages
  90
- Publisher
  メディカルビュー社
- Data Source
  KAKENHI-PROJECT-15H04918
[Book] Ｔ細胞を利用したがん免疫療法、医学のあゆみ2017
- Author(s)
  池田裕明
- Total Pages
  143
- Publisher
  医歯薬出版株式会社
- Data Source
  KAKENHI-PROJECT-15H04918
[Book] Ｔ細胞輸注療法の歴史（Ｔ細胞輸注法シリーズ１）、がん免疫療法2017
- Author(s)
  池田裕明
- Total Pages
  72
- Publisher
  メディカルビュー社
- Data Source
  KAKENHI-PROJECT-15H04918
[Book] 遺伝子改変T細胞を用いた免疫、がん分子標的治療2017
- Author(s)
  池田裕明
- Total Pages
  108
- Publisher
  メディカルビュー社
- Data Source
  KAKENHI-PROJECT-15H04918
[Book] Personalized Medicineとしてのがん免疫療法、遺伝子医学MOOK31 がん免疫療法2017
- Author(s)
  池田裕明
- Total Pages
  287
- Publisher
  ㈱メディカルドウ
- Data Source
  KAKENHI-PROJECT-15H04918
[Book] 細胞療法．細胞 The CELL．2016
- Author(s)
  池田裕明
- Publisher
  ニューサイエンス社
- Data Source
  KAKENHI-PROJECT-15H04918
[Book] 腫瘍特異的T細胞受容体(TCR)遺伝子導入T細胞療法医薬ジャーナル4月号2016
- Author(s)
  池田裕明
- Publisher
  医薬ジャーナル社
- Data Source
  KAKENHI-PROJECT-15H04918
[Book] 複合的がん免疫療法.免疫療法が効かないがんについての考察と展望　Cancer Board　がん免疫療法時代の航海図2016
- Author(s)
  池田裕明
- Publisher
  医学書院
- Data Source
  KAKENHI-PROJECT-15H04918
[Book] 医学のあゆみ　TIL/TCR遺伝子導入T細胞の養子免疫療法2016
- Author(s)
  池田裕明
- Publisher
  医歯薬出版株式会社
- Data Source
  KAKENHI-PROJECT-15H04918
[Book] TCR改変T細胞による食道がん治療　今、着実に実り始めた遺伝子治療ー最新研究と今後の展開ー　遺伝子医学MOOK2016
- Author(s)
  池田裕明．玖珠　洋
- Publisher
  メディカルドウ
- Data Source
  KAKENHI-PROJECT-15H04918
[Book] T細胞輸注朗報(TIL療法，TCR-T療法).　がん免疫療法　腫瘍免疫学の最新知見から治療法のアップデートまで　実験医学増刊2016
- Author(s)
  池田裕明
- Publisher
  羊土社
- Data Source
  KAKENHI-PROJECT-15H04918
[Book] 遺伝子改変T細胞を用いるがん免疫療法躍進するがん免疫療法　ファルマシア2016
- Author(s)
  池田裕明
- Publisher
  日本薬学会
- Data Source
  KAKENHI-PROJECT-15H04918
[Book] 薬剤学　がん治療ワクチンの可能性2016
- Author(s)
  池田裕明、原田直純
- Total Pages
  74
- Publisher
  日本薬剤学会
- Data Source
  KAKENHI-PROJECT-15H04918
[Book] TIL/TCR遺伝子導入T細胞の養子免疫療法　医学のあゆみ2016
- Author(s)
  池田裕明
- Publisher
  医歯薬出版株式会社
- Data Source
  KAKENHI-PROJECT-15H04918
[Book] 実験医学　最新がん免疫療法　（遺伝子改変T細胞を利用したがん免疫療法　がん患者の「治癒」をめざして）2015
- Author(s)
  池田裕明
- Publisher
  羊土社
- Data Source
  KAKENHI-PROJECT-15H04918
[Book] T細胞を用いた養子がん免疫療法の現状と展望2015
- Author(s)
  池田裕明
- Total Pages
  56
- Publisher
  メディカル・サイエンス・ダイジェスト　ニューサイエンス社
- Data Source
  KAKENHI-PROJECT-15H04918
[Book] 別冊・医学のあゆみ　がんの免疫制御 -研究と臨床の最前線　第16章　T細胞輸注療法2014
- Author(s)
  池田裕明、今井奈緒子
- Total Pages
  153
- Publisher
  医歯薬出版株式会社
- Data Source
  KAKENHI-PROJECT-24390300
[Book] 分子細胞治療フロンティア 20152014
- Author(s)
  土川貴裕、京極典憲、我孫子剛大、和田雅孝、宮谷内健吾、池田裕明、影山慎一、珠玖洋、平野聡
- Total Pages
  236
- Publisher
  株式会社パピルス
- Data Source
  KAKENHI-PROJECT-24390300
[Book] 実験医学　増刊号　腫瘍免疫学とがん免疫療法　第３章 1.　T細胞輸注療法 -TIL, T細胞クローン, 遺伝子改変T細胞2013
- Author(s)
  池田裕明、珠玖洋
- Total Pages
  229
- Publisher
  羊土社
- Data Source
  KAKENHI-PROJECT-24390300
[Book] カラー版内科学 : 6章内科疾患と腫瘍学、遺伝子治療・免疫療法2012
- Author(s)
  池田裕明、珠玖洋
- Publisher
  西村書店
- Data Source
  KAKENHI-PROJECT-24390300
[Book] Immunotherapy2012
- Author(s)
  Ikeda H
- Data Source
  KAKENHI-PROJECT-21591664
[Book] 日本臨床特集固形がんの免疫・抗体療法2012
- Author(s)
  池田裕明、珠玖洋
- Publisher
  日本臨床社
- Data Source
  KAKENHI-PROJECT-24390300
[Book] ドラッグデリバリーシステムの新展開II2012
- Author(s)
  珠玖洋、原田直純、池田裕明
- Publisher
  シーエムシー出版
- Data Source
  KAKENHI-PROJECT-21591664
[Book] Glioma : Immunotherapeutic approaches2011
- Author(s)
  Hiroaki Ikeda, Hiroshi Shiku
- Publisher
  Landes Bioscience and Springer Science+Business Media
- Data Source
  KAKENHI-PROJECT-21591664
[Book] がん生物学イラストレイテッド2011
- Author(s)
  今井奈緒子、池田裕明、珠玖洋
- Publisher
  羊土社
- Data Source
  KAKENHI-PROJECT-21591664
[Book] Immunotherapeutic approaches2011
- Author(s)
  Ikeda H, Shiku H
- URL
  http://www.landesbioscience.com/curie/
- Data Source
  KAKENHI-PROJECT-21591664
[Book] 日本臨床2011
- Author(s)
  池田裕明、珠玖洋
- Data Source
  KAKENHI-PROJECT-21591664
[Book] 臨床薬理第42巻第3号2011
- Author(s)
  池田裕明
- Publisher
  三原医学社
- Data Source
  KAKENHI-PROJECT-21591664
[Book] 日本臨床第69巻第9号2011
- Author(s)
  池田裕明、珠玖洋
- Publisher
  日本臨床社
- Data Source
  KAKENHI-PROJECT-21591664
[Book] 臨床薬理2011
- Author(s)
  池田裕明
- Data Source
  KAKENHI-PROJECT-21591664
[Book] CTL-がん免疫療法-実用化へのチャレンジ2010
- Author(s)
  池田裕明
- Publisher
  シーエムシー出版
- Data Source
  KAKENHI-PROJECT-21591664
[Book] SURGERY FRONTIER Vol.17 No.32010
- Author(s)
  今井奈緒子、池田裕明、岡本幸子、峰野純一、珠玖洋
- Total Pages
  6
- Publisher
  メディカルレビュー社
- Data Source
  KAKENHI-PROJECT-21591664
[Book] 遺伝子診断学2010
- Author(s)
  池田裕明、今井奈緒子、珠玖洋
- Data Source
  KAKENHI-PROJECT-21591664
[Book] SURGERY FRONTIER2010
- Author(s)
  今井奈緒子、池田裕明、岡本幸子、峰野純一、珠玖洋
- Data Source
  KAKENHI-PROJECT-21591664
[Book] 日本臨床増刊号遺伝子診断学(第2版) 68巻増刊号2010
- Author(s)
  池田裕明、今井奈緒子、珠玖洋
- Total Pages
  7
- Publisher
  日本臨床社
- Data Source
  KAKENHI-PROJECT-21591664
[Book] がん免疫療法-実用化へのチャレンジ-2010
- Author(s)
  池田裕明
- Total Pages
  11
- Publisher
  シーエムシー出版
- Data Source
  KAKENHI-PROJECT-21591664
[Book] 免疫異常2009
- Author(s)
  池田裕明、珠玖洋
- Publisher
  中山書店
- Data Source
  KAKENHI-PROJECT-21591664
[Book] 最新医学2009
- Author(s)
  池田裕明
- Data Source
  KAKENHI-PROJECT-21591664
[Book] 実験医学2009
- Author(s)
  池田裕明、珠玖洋
- Data Source
  KAKENHI-PROJECT-21591664
[Journal Article] T cell receptor gene‐modified allogeneic T cells with siRNA for endogenous T cell receptor induce efficient tumor regression without graft‐versus‐host disease2023
- Author(s)
  Satomi Okada, Daisuke Muraoka, Kiyoshi Yasui, Isao Tawara, Ayumi Kawamura, Sachiko Okamoto, Junichi Mineno, Naohiro Seo, Hiroshi Shiku, Susumu Eguchi, Hiroaki Ikeda
- Journal Title
  
  Cancer Science
  
  Volume: 114 Issue: 11 Pages: 4172-4183
- DOI
  10.1111/cas.15954
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-22K19532, KAKENHI-PROJECT-22K08876, KAKENHI-PROJECT-19K23919, KAKENHI-PROJECT-21H02990
[Journal Article] Chemical augmentation of mitochondrial electron transport chains tunes T cell activation threshold in tumors2022
- Author(s)
  Dotsu Yosuke、Muraoka Daisuke、Ogo Naohisa、Sonoda Yudai、Yasui Kiyoshi、Yamaguchi Hiroyuki、Yagita Hideo、Mukae Hiroshi、Asai Akira、Ikeda Hiroaki
- Journal Title
  
  Journal for ImmunoTherapy of Cancer
  
  Volume: 10 Issue: 2 Pages: e003958-e003958
- DOI
  10.1136/jitc-2021-003958
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-19K09048, KAKENHI-PROJECT-21H02609, KAKENHI-PROJECT-22K08876, KAKENHI-PROJECT-21H02990
[Journal Article] Prognostic significance of NY-ESO-1 antigen and PIGR expression in esophageal tumors of CHP-NY-ESO-1-vaccinated patients as adjuvant therapy.2022
- Author(s)
  Yasuhiro Nagata, Shinichi Kageyama, Takeshi Ishikawa, Satoshi Kokura, Tetsuya Okayama, Tetsuya Abe,...Hiroshi Shiku
- Journal Title
  
  Cancer immunology, immunotherapy : CII
  
  Volume: CII 71(11) Issue: 11 Pages: 2743-2755
- DOI
  10.1007/s00262-022-03194-5
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-21K06690, KAKENHI-PROJECT-21K08682, KAKENHI-PROJECT-22K19532, KAKENHI-PROJECT-22K19694, KAKENHI-PROJECT-21K16400, KAKENHI-PROJECT-21H04833, KAKENHI-PROJECT-21H02990, KAKENHI-PROJECT-23K24180
[Journal Article] Chimeric antigen receptor T-cell therapy targeting a MAGE A4 peptide and HLA-A*02:01 complex for unresectable advanced or recurrent solid cancer: protocol for a multi-institutional phase 1 clinical trial2022
- Author(s)
  Satoshi Okumura, Mikiya Ishihara, Naomi Kiyota, Kimikazu Yakushijin, Kohichi Takada, Shinichiro Kobayashi, Hiroaki Ikeda, Makoto Endo, Koji Kato, Shigehisa Kitano, Akihiko Matsumine, Yasuhiro Nagata,...Hiroshi Shiku
- Journal Title
  
  BMJ Open
  
  Volume: 12(11) Issue: 11 Pages: e065109-e065109
- DOI
  10.1136/bmjopen-2022-065109
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-21K06690, KAKENHI-PROJECT-21K08682, KAKENHI-PROJECT-22K08080, KAKENHI-PROJECT-22K08876, KAKENHI-PROJECT-22K19532, KAKENHI-PROJECT-21K16400, KAKENHI-PROJECT-21H02990, KAKENHI-PROJECT-20K09731, KAKENHI-PROJECT-23K24456, KAKENHI-PROJECT-23K24180
[Journal Article] NY-ESO-1-specific redirected T cells with endogenous TCR knockdown mediate tumor response and cytokine release syndrome2022
- Author(s)
  Ishihara M, Kitano S, Kageyama S, Miyahara Y, Yamamoto N, Kato H, Mishima H, Hattori H, Funakoshi T, Kojima T, Sasada T, Sato E, Okamoto S, Tomura D, Nukaya I, Chono H, Mineno J, Kairi MF, Diem Hoang Nguyen P, Simoni Y, Nardin A, Newell E, Fehlings M, Ikeda H, Watanabe T, Shiku H.
- Journal Title
  
  J Immunother Cancer
  
  Volume: 10 Issue: 6 Pages: e003811-e003811
- DOI
  10.1136/jitc-2021-003811
- Peer Reviewed / Open Access / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-21K08682, KAKENHI-PROJECT-22K08876, KAKENHI-PROJECT-22K19532, KAKENHI-PROJECT-21H02990, KAKENHI-PROJECT-21H02995, KAKENHI-PROJECT-23K24180
[Journal Article] 固形がんを標的としたCAR-T細胞療法2021
- Author(s)
  安井潔、池田裕明
- Journal Title
  
  BIO Clinica
  
  Volume: 11 Pages: 26-30
- Data Source
  KAKENHI-PROJECT-19K09048
[Journal Article] Real-world Incidence of Febrile Neutropenia among Patients treated with Single-agent Amrubicin: Necessity of the Primary Prophylactic Administration of Granulocyte Colony-stimulating Factor.2021
- Author(s)
  Dotsu Y, Yamaguchi H, Fukuda M, Suyama T, Honda N, Umeyama Y, Taniguch H, Gyotoku H, Takemoto S, Tagawa R, Ogata R Tomono H, Shimada M, Senju H, Nakatom K, Nagashima S, Soda H, Ikeda H, Ashizawa K, Mukae H.
- Journal Title
  
  Journal of Clinical Medicine
  
  Volume: 10 Issue: 18 Pages: 4221-4221
- DOI
  10.3390/jcm10184221
- NAID
  120007174512
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-21H02990
[Journal Article] Dabrafenib and trametinib therapy in an elderly patient with non-small cell lung cancer harboring the BRAF V600E mutation.2020
- Author(s)
  Dotsu Y, Fukuda M, Honda N, Gyotoku H, Kohno Y, Suyama T, Umeyama Y, Taniguchi H, Takemoto S, Yamaguchi H, Miyazaki T, Sakamoto N, Obase Y, Ikeda H, Ashizawa K, Mukae H.
- Journal Title
  
  Thorac Cancer
  
  Volume: 12 Issue: 2 Pages: 272-276
- DOI
  10.1111/1759-7714.13756
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-18H02872, KAKENHI-PROJECT-18K19584
[Journal Article] First-in-human phase I clinical trial of the NY-ESO-1 protein cancer vaccine with NOD2 and TLR9 stimulants in patients with NY-ESO-1-expressing refractory solid tumors.2020
- Author(s)
  Ishihara M, Tono Y, Miyahara Y, Muraoka D, Harada N, Kageyama S, Sasaki T, Hori Y, Soga N, Uchida K, Shiraishi T, Sato E, Kanda H, Mizuno T, Webster GA, Ikeda H, Katayama N, Sugimura Y, Shiku H.
- Journal Title
  
  Cancer Immunol Immunother
  
  Volume: 69 Issue: 4 Pages: 663-675
- DOI
  10.1007/s00262-020-02483-1
- Peer Reviewed / Open Access / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-19K09048, KAKENHI-PROJECT-18K19584, KAKENHI-PROJECT-19K21599, KAKENHI-PROJECT-18H02872, KAKENHI-PROJECT-17K09923, KAKENHI-PROJECT-19K22655, KAKENHI-PROJECT-19H03729
[Journal Article] Identification of a dominant CD8+ CTL epitope in the SARS-associated coronavirus 2 spike protein.2020
- Author(s)
  Muraoka D, Situo D, Sawada SI, Akiyoshi K, Harada N, Ikeda H.
- Journal Title
  
  Vaccine
  
  Volume: 38 Issue: 49 Pages: 7697-7701
- DOI
  10.1016/j.vaccine.2020.10.039
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-18H02872, KAKENHI-PROJECT-18K19584
[Journal Article] MAGE-A4, NY-ESO-1 and SAGE mRNA expression rates and co-expression relationships in solid tumours2020
- Author(s)
  Ishihara Mikiya、Kageyama Shinichi、Miyahara Yoshihiro、Ishikawa Takeshi、Ueda Shugo、Soga Norihito、Naota Hiroaki、Mukai Katsumi、Harada Naozumi、Ikeda Hiroaki、Shiku Hiroshi
- Journal Title
  
  BMC Cancer
  
  Volume: 20 Issue: 1 Pages: 606-606
- DOI
  10.1186/s12885-020-07098-4
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-19K21599, KAKENHI-PROJECT-19K22655, KAKENHI-PROJECT-18H02872, KAKENHI-PROJECT-18K19584
[Journal Article] がん免疫における新規治療アプローチ　2)TCR-T細胞によるがん治療2020
- Author(s)
  安井潔、池田裕明
- Journal Title
  
  腫瘍内科
  
  Volume: 26 Pages: 71-78
- Data Source
  KAKENHI-PROJECT-19K09048
[Journal Article] CD4+ T cells support polyfunctionality of cytotoxic CD8+ T cells with memory potential in immunological control of tumor.2020
- Author(s)
  Naoko Imai, Isao Tawara, Makiko Yamane, Daisuke Muraoka, Hiroshi Shiku, Hiroaki Ikeda.
- Journal Title
  
  Cancer Science
  
  Volume: 111 Issue: 6 Pages: 1958-1968
- DOI
  10.1111/cas.14420
- Peer Reviewed / Open Access / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-18H02872, KAKENHI-PROJECT-18K19584
[Journal Article] Immunohistochemical expression and clinicopathological assessment of the cancer testis antigens NY-ESO-1 and MAGE-A4 in high-grade soft-tissue sarcoma.2019
- Author(s)
  Kakimoto T, Matsumine A, Kageyama S, Asanuma K, Matsubara T, Nakamura T, Iino T, Ikeda H, Shiku H, Sudo A
- Journal Title
  
  Oncology Letters
  
  Volume: 17 Pages: 3937-3943
- DOI
  10.3892/ol.2019.10044
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-18K19584, KAKENHI-PROJECT-18H02872, KAKENHI-PROJECT-19K22655, KAKENHI-PROJECT-16K10856
[Journal Article] Antigen delivery targeted to tumor-associated macrophages overcomes tumor immune resistance2019
- Author(s)
  Muraoka Daisuke、Seo Naohiro、Hayashi Tae、Tahara Yoshiro、Fujii Keisuke、Tawara Isao、Miyahara Yoshihiro、Okamori Kana、Yagita Hideo、Imoto Seiya、Yamaguchi Rui、Komura Mitsuhiro、Miyano Satoru、Goto Masahiro、Sawada Shin-ichi、Asai Akira、Ikeda Hiroaki、Akiyoshi Kazunari、Harada Naozumi、Shiku Hiroshi
- Journal Title
  
  Journal of Clinical Investigation
  
  Volume: 129 Issue: 3 Pages: 1278-1294
- DOI
  10.1172/jci97642
- NAID
  120006987781
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-17K07222, KAKENHI-PROJECT-18K19584, KAKENHI-PROJECT-18H02559, KAKENHI-PROJECT-18H02872, KAKENHI-PROJECT-18H03328, KAKENHI-PROJECT-18K19474, KAKENHI-PROJECT-16H06369, KAKENHI-PROJECT-16K07168
[Journal Article] Pertuzumab, trastuzumab and eribulin mesylate therapy for previously treated advanced HER2-positive breast cancer: a feasibility study with analysis of biomarkers2018
- Author(s)
  Tono Yasutaka、Ishihara Mikiya、Miyahara Yoshihiro、Tamaru Satoshi、Oda Hiroyasu、Yamashita Yoshiki、Tawara Isao、Ikeda Hiroaki、Shiku Hiroshi、Mizuno Toshiro、Katayama Naoyuki
- Journal Title
  
  Oncotarget
  
  Volume: 9 Issue: 19 Pages: 14909-14921
- DOI
  10.18632/oncotarget.24504
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-15H04918, KAKENHI-PROJECT-18K19584, KAKENHI-PROJECT-18H02872
[Journal Article] MicroRNA-3662 expression correlates with antiviral drug resistance in adult T-cell leukemia/lymphoma cells.2018
- Author(s)
  Yasui K, Izumida M, Nakagawa T, Kubo Y, Hayashi H, Ito T, Ikeda H, Matsuyama T
- Journal Title
  
  Biochem Biophys Res Commun
  
  Volume: 印刷中 Issue: 4 Pages: 833-837
- DOI
  10.1016/j.bbrc.2018.04.159
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-16K15319, KAKENHI-PROJECT-17H04044, KAKENHI-PROJECT-17K07287, KAKENHI-PROJECT-18K19584, KAKENHI-PROJECT-18H02872
[Journal Article] Kageyama S. NY-ESO-1 antigen expression and immune response are associated with poor prognosis in MAGE-A4-vaccinated patients with esophageal or head/neck squamous cell carcinoma.2018
- Author(s)
  Ueda S, Miyahara Y, Nagata Y, Sato E, Shiraishi T, Harada N, Ikeda H, Shiku H
- Journal Title
  
  Oncotarget
  
  Volume: 13 Issue: 89 Pages: 35997-36011
- DOI
  10.18632/oncotarget.26323
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-18K19584, KAKENHI-PROJECT-18H02872
[Journal Article] Antitumor activity of CAR-T cells targeting the intracellular oncoprotein WT1 can be enhanced by vaccination.2018
- Author(s)
  Akahori Y, Wang L, Yoneyama M, Seo N, Okumura S, Miyahara Y, Amaishi Y, Okamoto S, Mineno J, Ikeda H, Maki T, Fujiwara H, Akatsuka Y, Kato T, Shiku H.
- Journal Title
  
  Blood. 2018 Sep 13;132(11):
  
  Volume: 132 Issue: 11 Pages: 1134-1145
- DOI
  10.1182/blood-2017-08-802926
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-18K08341, KAKENHI-PROJECT-18K08361, KAKENHI-PROJECT-18K19474, KAKENHI-PROJECT-18K19584, KAKENHI-PROJECT-18H02872, KAKENHI-PROJECT-16K09533
[Journal Article] Serum immunoglobulin E response as a marker for unfavorable prognosis following cholesteryl pullulan-MAGE A4 vaccination2018
- Author(s)
  Abiko Takehiro、Tsuchikawa Takahiro、Miyauchi Kengo、Wada Masataka、Kyogoku Noriaki、Shichinohe Toshiaki、Miyahara Yoshihiro、Kageyama Shinichi、Ikeda Hiroaki、Shiku Hiroshi、Hirano Satoshi
- Journal Title
  
  Oncology Letters
  
  Volume: 15 Pages: 3703-3711
- DOI
  10.3892/ol.2018.7767
- Peer Reviewed / Open Access / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-15H04918, KAKENHI-PROJECT-15K10093, KAKENHI-PROJECT-18K19584, KAKENHI-PROJECT-18H02872
[Journal Article] Activated CD8+ T cell extracellular vesicles prevent tumour progression by targeting of lesional mesenchymal cells2018
- Author(s)
  Seo Naohiro、Shirakura Yoshitaka、Tahara Yoshiro、Momose Fumiyasu、Harada Naozumi、Ikeda Hiroaki、Akiyoshi Kazunari、Shiku Hiroshi
- Journal Title
  
  Nature Communications
  
  Volume: 9 Issue: 1 Pages: 435-435
- DOI
  10.1038/s41467-018-02865-1
- NAID
  120006532079
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-15H04918, KAKENHI-PROJECT-18K19474, KAKENHI-PROJECT-18K19584, KAKENHI-PROJECT-18H02872
[Journal Article] Prognostic value of MAGEA4 in primary lung cancer depends on subcellular localization and p53 status.2018
- Author(s)
  Fujiwara-Kuroda A, Kato T, Abiko T, Tsuchikawa T, Kyogoku N, Ichinokawa M, Tanaka K, Noji T, Hida Y, Kaga K, Matsui Y, Ikeda H, Kageyama S, Shiku H, Hirano S
- Journal Title
  
  International Journal of Oncology
  
  Volume: 53 Pages: 713-724
- DOI
  10.3892/ijo.2018.4425
- NAID
  120006709281
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-18K19584, KAKENHI-PROJECT-18H02872
[Journal Article] Clinical Implications of CD4+CD25+Foxp3+Regulatory T Cell Frequencies After CHP-MAGE-A4 Cancer Vaccination2018
- Author(s)
  Wada M, Tsuchikawa T, Kyogoku N, Abiko T, Miyauchi K, Takeuchi S, Kuwatani T, Shichinohe T, Miyahara Y, Kageyama S, Ikeda H, Shiku H, Hirano S.
- Journal Title
  
  Anticancer Research
  
  Volume: 38 Issue: 3 Pages: 1435-1444
- DOI
  10.21873/anticanres.12368
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-15H04918, KAKENHI-PROJECT-18K19584, KAKENHI-PROJECT-18H02872
[Journal Article] IFN-γ is required for cytotoxic T cell-dependent cancer genome immunoediting.2017
- Author(s)
  Takeda K, Nakayama M, Hayakawa Y, Kojima Y, Ikeda H, Imai N, Ogasawara K, Okumura K, Thomas DM, Smyth MJ
- Journal Title
  
  Nat Commun.
  
  Volume: 8 Issue: 1 Pages: 14607-14607
- DOI
  10.1038/ncomms14607
- Peer Reviewed / Acknowledgement Compliant / Open Access / Int'l Joint Research
- Data Source
  KAKENHI-PLANNED-16H06497, KAKENHI-PROJECT-15H04918, KAKENHI-PROJECT-16H02960, KAKENHI-PROJECT-16H05530, KAKENHI-PROJECT-26460397, KAKENHI-PROJECT-15K14410, KAKENHI-PROJECT-16K15112
[Journal Article] Safety and persistence of WT1-specific T-cell receptor gene-transduced lymphocytes in patients with AML and MDS.2017
- Author(s)
  Tawara I, Kageyama S, Miyahara Y, Fujiwara H, Nishida T, Akatsuka Y, Ikeda H, Tanimoto K, Terakura S, Murata M, Inaguma Y, Masuya M, Inoue N, Kidokoro T, Okamoto S, Tomura D, Chono H, Nukaya I, Mineno J, Naoe T, Emi N, Yasukawa M, Katayama N, Shiku H.
- Journal Title
  
  Blood
  
  Volume: 130 Issue: 18 Pages: 1985-1994
- DOI
  10.1182/blood-2017-06-791202
- Peer Reviewed / Open Access / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-16K09307, KAKENHI-PROJECT-17K09923, KAKENHI-PROJECT-17K09949, KAKENHI-PROJECT-17K09957, KAKENHI-PROJECT-15H04858, KAKENHI-PROJECT-15H04918, KAKENHI-PROJECT-15K09497, KAKENHI-PROJECT-15K09498, KAKENHI-PROJECT-15K09506, KAKENHI-PROJECT-15K10093
[Journal Article] Differential detection of cytoplasmic Wilms tumor 1 expression by immunohistochemistry, Western blotting, and mRNA quantification.2017
- Author(s)
  Maki T, Ikeda H, Kuroda A, Kyogoku N, Yamamura Y, Tabata Y, Abiko T, Tsuchikawa T, HidaY, ShichinoheT, Tanaka E, Kaga K, Hatanaka K, MatsunoY, Imai N, Satoshi Hirano.
- Journal Title
  
  International Journal of Oncology
  
  Volume: 50 Issue: 1 Pages: 129-140
- DOI
  10.3892/ijo.2016.3786
- NAID
  120006313439
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-15H04918
[Journal Article] Clinical relevance of antigen spreading pattern induced by CHP-MAGE-A4 cancer vaccination2016
- Author(s)
  Miyauchi K, Tsuchikawa T, Wada M, Abiko T, Kyogoku N, Shichinohe T, Miyahara Y, Kageyama S, Ikeda H, Shiku H, Hirano S.
- Journal Title
  
  Immunotherapy
  
  Volume: 印刷中 Issue: 5 Pages: 527-40
- DOI
  10.2217/imt-2016-0007
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-15K10093, KAKENHI-PROJECT-15H04918, KAKENHI-PROJECT-26461935
[Journal Article] Time-dependent transition of the immunoglobulin G subclass and immunoglobulin E response in cancer patients vaccinated with cholesteryl pullulan-melanoma antigen gene-A4 nanogel.2016
- Author(s)
  Kyogoku N, Ikeda H, Tsuchikawa T, Abiko T, Fujiwara A, Maki T, Yamamura Y, Ichinokawa M, Tanaka K, Imai N, Miyahara Y, Kageyama S, Shiku H, Hirano S.
- Journal Title
  
  Oncology Letters
  
  Volume: 12 Issue: 6 Pages: 4493-4504
- DOI
  10.3892/ol.2016.5253
- NAID
  120005981404
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-15H04918, KAKENHI-PROJECT-26461935, KAKENHI-PROJECT-15K10093
[Journal Article] T-cell adoptive immunotherapy using tumor-infiltrating T cells and genetically engineered TCR-T cells.2016
- Author(s)
  Ikeda H
- Journal Title
  
  International Immunology
  
  Volume: 28 Issue: 7 Pages: 349-353
- DOI
  10.1093/intimm/dxw022
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-15H04918
[Journal Article] Adoptive immunotherapy of cancer utilizing genetically engineered lymphocytes.2015
- Author(s)
  Ikeda H, Shiku H.
- Journal Title
  
  Cancer Immunology, Immunotherapy
  
  Volume: 64 Issue: 7 Pages: 903-909
- DOI
  10.1007/s00262-015-1718-0
- Peer Reviewed / Acknowledgement Compliant
- Data Source
  KAKENHI-PROJECT-15H04918
[Journal Article] 2015 Guidance on cancer immunotherapy development in early-phase clinical studies2015
- Author(s)
  Guidance Development Review Committee; Working Group for Clinical Studies of Cancer Immunotherapy; Working Group for Effector Cell Therapy; Working Group for CMC/Non-clinical Studies; Working Group for Cancer Vaccines and Adjuvants; Working Group for Anti-immune Checkpoint Therapy and Comprehensive Cancer
- Journal Title
  
  Cancer Sci
  
  Volume: 106 Issue: 12 Pages: 1761
- DOI
  10.1111/cas.12819
- Peer Reviewed / Open Access / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-15K10093, KAKENHI-PROJECT-26221005, KAKENHI-PROJECT-15H04918, KAKENHI-PROJECT-26293308
[Journal Article] Adoptive transfer of MAGE-A4 T-cell receptor gene-transduced lymphocytes in patients with recurrent esophageal cancer2015
- Author(s)
  Kageyama S, Ikeda H, Miyahara Y, Imai N, Ishihara M, Saito K, Sugino S, Ueda S, Ishikawa T, Kokura S, Naota H, Ohishi K, Shiraishi T, Inoue N, Tanabe M, Kidokoro T, Yoshioka H, Tomura D, Nukaya I, Mineno J, Takesako K, Katayama N, Shiku H.
- Journal Title
  
  Clinical Cancer Research
  
  Volume: in press Issue: 10 Pages: 2268-2277
- DOI
  10.1158/1078-0432.ccr-14-1559
- Peer Reviewed / Acknowledgement Compliant / Open Access
- Data Source
  KAKENHI-PROJECT-24591939, KAKENHI-PROJECT-25350612, KAKENHI-PROJECT-25461413, KAKENHI-PROJECT-15K10093, KAKENHI-PROJECT-15H04918, KAKENHI-PROJECT-25461447
[Journal Article] Systemic CD8+ T Cell-Mediated Tumoricidal Effects by Intratumoral Treatment of Oncolytic Herpes Simplex Virus with the Agonistic Monoclonal Antibody for Murine Glucocorticoid-Induced Tumor Necrosis Factor Receptor.2014
- Author(s)
  Ishihara M, Seo N, Mitsui J, Muraoka D, Tanaka M, Mineno J, Ikeda H, Shiku H.
- Journal Title
  
  PLoS One
  
  Volume: 9 Issue: 8 Pages: e104669-e104669
- DOI
  10.1371/journal.pone.0104669
- Peer Reviewed / Acknowledgement Compliant / Open Access
- Data Source
  KAKENHI-PROJECT-24390300, KAKENHI-PROJECT-25830115
[Journal Article] Interleukin-17D mediates tumor rejection through recruitment of natural killer cells.2014
- Author(s)
  O'Sullivan T, Saddawi-Konefka R, Gross E, Tran M, Mayfield SP, Ikeda H, Bui JD.
- Journal Title
  
  Cell Report
  
  Volume: 7 Issue: 4 Pages: 989-998
- DOI
  10.1016/j.celrep.2014.03.073
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-24390300
[Journal Article] Stimulation through very late antigen-4 and -5 improves the multifunctionality and memory formation of CD8+ T cells.2014
- Author(s)
  Hosoi H, Ikeda H, Imai N, Amaike C, Wang L, Orito Y, Yamane M, Ueno H, Ideno M, Nukaya I, Enoki T, Mineno J, Takesako K, Hirano S, Shiku H.
- Journal Title
  
  European Journal of Immunology
  
  Volume: 44 Issue: 6 Pages: 1727-1758
- DOI
  10.1002/eji.201343969
- Peer Reviewed / Acknowledgement Compliant / Open Access
- Data Source
  KAKENHI-PROJECT-24390300
[Journal Article] Adoptive transfer of genetically engineered WT1-specific cytotoxic T lymphocytes does not induce renal injury2014
- Author(s)
  Asai H, Fujiwara H, Kitazawa S, Kobayashi N, Ochi T, Miyazaki Y, Ochi F, Akatsuka Y, Okamoto S, Mineno J, Kuzushima K, Ikeda H, Shiku H, Yasukawa M
- Journal Title
  
  J Hematol Oncol.
  
  Volume: 7 Issue: 1 Pages: 3-3
- DOI
  10.1186/1756-8722-7-3
- Peer Reviewed / Acknowledgement Compliant / Open Access
- Data Source
  KAKENHI-PROJECT-12F02773, KAKENHI-PROJECT-24390245, KAKENHI-PROJECT-24390300, KAKENHI-PROJECT-24591426, KAKENHI-PROJECT-24591435, KAKENHI-PROJECT-26670467
[Journal Article] Limited expression of cancer-testis antigen in renal eell carcinoma patients.2013
- Author(s)
  Soga N, Hori Y, Yamakado K, Ikeda H, Imai N, Kageyama S, Nakase K, Yuta A, Hayashi N, Shiku H, S
- Journal Title
  
  Mol. Clin. Oncol.
  
  Volume: 1 Issue: 2 Pages: 326-330
- DOI
  10.3892/mco.2012.40
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-24390300, KAKENHI-PROJECT-24590913
[Journal Article] Adoptive transfer of genetically modified Wilms' tumor 1-specific T cells in a novel malignant skull base meningioma model.2013
- Author(s)
  Iwami K, Natsume A, Ohno M, Ikeda H, Mineno J, Nukaya I, Okamoto S, Fujiwara H, Yasukawa M, Shiku H, Wakabayashi T.
- Journal Title
  
  Neuro Oncol.
  
  Volume: 15 Issue: 6 Pages: 747-758
- DOI
  10.1093/neuonc/not007
- Peer Reviewed
- Data Source
  KAKENHI-PLANNED-23107010, KAKENHI-PROJECT-24249073, KAKENHI-PROJECT-24390245, KAKENHI-PROJECT-24390300, KAKENHI-PROJECT-24591426
[Journal Article] Dose-dependent effects of NY-ESO-1 protein vaccine complexed with cholesteryl pullulan (CHP-NY-ESO-1) on immune responses and survival benefits of esophageal cancer patients2013
- Author(s)
  Kageyama S, Wada H, Muro K, Niwa Y, Ueda S, Miyata H, Takiguchi S, Sugino SH, Miyahara Y, Ikeda H, Imai N, Sato E, Yamada T, Osako M, Ohnishi M, Harada N, Hishida T, Doki Y, Shiku H
- Journal Title
  
  Journal of translational medicine
  
  Volume: 5;11 Issue: 1 Pages: 246-246
- DOI
  10.1186/1479-5876-11-246
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-23501284, KAKENHI-PROJECT-24390300, KAKENHI-PROJECT-24591939, KAKENHI-PROJECT-24591965, KAKENHI-PROJECT-24650259
[Journal Article] T-cell receptor gene therapy targeting melanoma-associated antigen-A4 inhibits human tumor growth in non-obese diabetic/SCID/gc_null mice2012
- Author(s)
  Shirakura Y Mizuno Y, Wang L, Imai N, Amaike C, Sato E, Ito M, Nukaya I, Mineno J, Takesako K, Ikeda H, Shiku H
- Journal Title
  
  Cancer Sci
  
  Volume: 103(1) Pages: 17-25
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-21591664
[Journal Article] A promising vector for TCR gene therapy: differential effect of siRNA, 2A peptide, and disulfide bond on the introduced TCR expression.2012
- Author(s)
  Okamoto S, et al.
- Journal Title
  
  Mol Ther Nucleic Acids.
  
  Volume: 18 Pages: e63-e63
- DOI
  10.1038/mtna.2012.52
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-23659489, KAKENHI-PROJECT-24390245, KAKENHI-PROJECT-24390300, KAKENHI-PROJECT-24591426
[Journal Article] Intracellular tumor-associated antigens represent effective targets for passive immunotherapy2012
- Author(s)
  Noguchi T, Kato T, Wang L, Maeda Y, Ikeda H, Sato E, Knuth A, Gnjatic S, Ritter G, Sakaguchi S, Old LJ, Shiku H, Nishikawa H
- Journal Title
  
  Cancer Research
  
  Volume: (Epub ahead of print)
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-21591664
[Journal Article] Intracellular tumor-associated antigens represent effective targets for passive immunotherapy2012
- Author(s)
  Noguchi T, Kato T, Wang L, Maeda Y, Ikeda H, Sato E, Knuth A, Gnjatic S, Ritter G, Sakaguchi S, Old LJ, Shiku H, Nishikawa H
- Journal Title
  
  Cancer Res
  
  Volume: 72(7) Pages: 1672-1682
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-21591664
[Journal Article] T-cell receptor gene therapy targeting melanoma-associated antigen-A4 inhibits human tumor growth in non-obese diabetic/SCID/γc^<null> mice2012
- Author(s)
  Shirakura Y, Mizuno Y, Wang L, Imai N, Amaike C, Sato E, Ito M, Nukaya I, Mineno J, Takesako K, Ikeda H, Shiku H
- Journal Title
  
  Cancer Science
  
  Volume: 103 Issue: 1 Pages: 17-25
- DOI
  10.1111/j.1349-7006.2011.02111.x
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-21591664, KAKENHI-PROJECT-22220007, KAKENHI-PROJECT-22791274, KAKENHI-PROJECT-24590913
[Journal Article] Gene-modified lymphocytes : from caution to promise for effective cancer immunotherapy.2012
- Author(s)
  Ikeda H
- Journal Title
  
  Immunotherapy
  
  Volume: 4 Issue: 3 Pages: 241-244
- DOI
  10.2217/imt.12.1
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-24390300
[Journal Article] Intracellular Tumor-Associated Antigens Represent Effective Targets for Passive Immunotherapy2012
- Author(s)
  Noguchi, T., T.Kato, L.Wang, Y.Maeda, H.Ikeda, E.Sato, A.Knuth, S.Gnjatic, G.Ritter, S.Sakaguchi, L.J.Old, H.Shiku, H.Nishikawa
- Journal Title
  
  Cancer Research
  
  Volume: 72 Issue: 7 Pages: 1672-1682
- DOI
  10.1158/0008-5472.can-11-3072
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-21510067, KAKENHI-PROJECT-23300354, KAKENHI-PROJECT-24390300
[Journal Article] Association of CD8+ T cell infiltration in esophageal carcinomalesions with HLA class I antigen expression and survival2011
- Author(s)
  Tsuchikawa T, Ikeda H, Cho Y, Miyamoto M, Shichinohe T, Hirano S, Kondo S.
- Journal Title
  
  Clinical And Experimental Immunology
  
  Volume: 164 Pages: 50-56
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-21591664
[Journal Article] siRNA-mediated silencing of PD-1 ligands enhances tumor-specific human T-cell effector functions2011
- Author(s)
  Iwamura, K., T.Kato, Y.Miyahara, H.Naota, J.Mineno, H.Ikeda, H.Shiku
- Journal Title
  
  Gene Therapy
  
  Volume: (印刷中) Issue: 10 Pages: 959-966
- DOI
  10.1038/gt.2011.185
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-21510067, KAKENHI-PROJECT-21591664
[Journal Article] Association of CD8^+ T cell infiltration in esophageal carcinomalesions with HLA class I antigen expression and survival2011
- Author(s)
  Tsuchikawa, T, Ikeda H, Cho Y, Miyamoto M, Shichinohe, T, Hirano S, Kondo S
- Journal Title
  
  Clin Exp Immunol
  
  Volume: 164(1) Pages: 50-6
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-21591664
[Journal Article]2009
- Author(s)
  池田裕明, 珠玖洋
- Journal Title
  
  実験医学 2009年9月号 Vol. 27, No. 14(羊土社)
  
  Pages: 2176-2184
- Data Source
  KAKENHI-PROJECT-21591664
[Journal Article]2009
- Author(s)
  池田裕明
- Journal Title
  
  最新医学 2009年11月号 Vol. 64, No. 11(最新医学社)
  
  Pages: 86-93
- Data Source
  KAKENHI-PROJECT-21591664
[Journal Article] GITR stimulation enhances multifunctionality of adoptively transferred tumor antigen-specific CD8^+ T cells with tumor regression2009
- Author(s)
  Imai N, Ikeda H, Tawara I, Wang L, Wang L, Nishikawa H, Kato T, Shiku H
- Journal Title
  
  Cancer Science 100
  
  Pages: 1317-1325
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-21591664
[Journal Article]2009
- Author(s)
  池田裕明, 珠玖洋
- Journal Title
  
  内科学書改訂第7版(中山書店)
  
  Pages: 34-42
- Data Source
  KAKENHI-PROJECT-21591664
[Journal Article] Improved expression and reactivity of transduced tumor-specific TCRs in human lymphocytes by silencing of endogenous TCR2009
- Author(s)
  Okamoto S, Mineno J, Ikeda H, Fujiwara H, Yasukawa M, Shiku H, Kato I.
- Journal Title
  
  Cancer Research 69
  
  Pages: 9003-9011
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-21591664
[Journal Article] Antibody responses against NY-ESO-1 and HER2 antigens in patients vaccinated with combinations of cholesteryl pullulan (CHP)-NY-ESO-1 and CHP-HER2 with OK-4322009
- Author(s)
  Aoki M, Ueda S, Nishikawa H, Kitano S, Hirayama M, Ikeda H, Toyoda H, Tanaka K, Kanai M, Takabayashi A, Imai H, Shiraishi T, Sato E, Wada H, Nakayama E, Takei Y, Katayama N, Shiku H, Kageyama S
- Journal Title
  
  Vaccine 27
  
  Pages: 6854-6861
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-21591664
[Journal Article] Antibody responses against NY-ESO-1 and HER2 antigens in patients vaccinated with combinations of cholesteryl pullulan(CHP)-NY-ESO-1 and CHP-HER2 with OK-4322009
- Author(s)
  Aoki M, Ueda S, Nishikawa H, Kitano S, Hirayama M, Ikeda H, Toyoda H, Tanaka K, Kanai M, Takabayashi A, Imai H, Shiraishi T, Sato E, Wada H, Nakayama E, Takei Y, Katayama N, Shiku H, Kageyama S
- Journal Title
  
  Vaccine
  
  Volume: 7(49) Pages: 6854-61
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-21591664
[Journal Article] Improved expression and reactivity of transduced tumor-specific TCRs in human lymphocytes by silencing of endogenous TCR2009
- Author(s)
  Okamoto S, Mineno J, Ikeda H, Fujiwara H, Yasukawa M, Shiku H, Kato I
- Journal Title
  
  Cancer Res
  
  Volume: 69(23) Pages: 9003-11
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-21591664
[Journal Article] GITR stimulation enhances multifunctionality of adoptively transferred tumor antigen-specific CD8^+ T cells with tumor regression2009
- Author(s)
  Imai N, Ikeda H, Tawara I, Wang L, Wang L, Nishikawa H, Kato T, Shiku H
- Journal Title
  
  Cancer Sci
  
  Volume: 100(7) Pages: 1317-1325
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-21591664
[Journal Article] Identification of a novel NY-ESO-1 promiscuous helper epitope presented by multiple MHC class II molecules found frequently in the Japanese population2007
- Author(s)
  Ohkuri T, Sato M, Abe H, Tsuji K, Yamagishi Y, Ikeda H, Matsubara N, Kitamura H, Nishimura T.
- Journal Title
  
  Cancer Science 98
  
  Pages: 1092-1098
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-18591534
[Journal Article] Identification of a novel NY-ESO-1 promiscuous helper epitope presented by multiple MHC class II molecules found frequently in the Japanese population2007
- Author(s)
  Ohkuri, T, Sato, M, Abe, H, Tsuji, K, Yamagishi, Y, Ikeda, H, Matsubara, N, Kitamura, H, Nishimura, T
- Journal Title
  
  Cancer Science 98
  
  Pages: 1092-1098
- Description
  「研究成果報告書概要(欧文)」より
- Data Source
  KAKENHI-PROJECT-18591534
[Journal Article] Identification of CLUAP1 as a human osteosarcoma tumor-associated antigen recognized by the humoral immune system2007
- Author(s)
  Ishikura, H, Ikeda, H, Abe, H, Ohkuri, T, Hiraga, H, Isu, K, Tsukahara, T, Sato, N, Minami, A, Nishimura, T
- Journal Title
  
  International Journal of Oncology 30
  
  Pages: 461-467
- Description
  「研究成果報告書概要(欧文)」より
- Data Source
  KAKENHI-PROJECT-18591534
[Journal Article] Identification of anovel NY-ESO-1 promiscuous helper epitope presented by multiple MHC class II molecules found frequently in the Japanese population2007
- Author(s)
  Ohkuri T, Sato M, Abe H, Tsuji K, Yamagishi Y, Ikeda H, Matsubara N, Kitamura H, Nishimura T.
- Journal Title
  
  Cancer Science 98
  
  Pages: 1092-1098
- Description
  「研究成果報告書概要(和文)」より
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-18591534
[Journal Article] Identification of CLUAP1 as a human osteosarcoma tumor-associated antigen recognized by the humoral immune system.2007
- Author(s)
  Ishikura H, Ikeda H, Abe H, Ohkuri T, Hiraga H, Isu K, Tsukahara T, Sato N, Minami A, Nishimura T
- Journal Title
  
  International Journal of Oncology 30
  
  Pages: 461-467
- Description
  「研究成果報告書概要(和文)」より
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-18591534
[Journal Article] Antitumor activity of chimeric immunoreceptor gene-modified Tcl and Thl cells against autologous carcinoembryonic antigen-expressing coloncancer cells.2006
- Author(s)
  Sasaki T, Ikeda, H, Sato M, Ohkuri T, Abe H, Kuroki M, Onodera M, Miyamoto M, Kondo S, Nishimura, T
- Journal Title
  
  Cancer Science 97
  
  Pages: 920-927
- Data Source
  KAKENHI-PROJECT-18591534
[Journal Article] An essential role of. antigen-presenting cell/T-helper type 1 cell-cell interactions in draining lymph node during complete eradication of class II-negative tumor tissue by T-helper type 1 cell therapy2006
- Author(s)
  Chamoto, K, Wakita, D, Narita, Y, Zhang, Y, Noguchi, D, Ohnishi, H, Iguchi, T, Sakai, T, Ikeda, H, Nishimura, T
- Journal Title
  
  Cancer Research 66
  
  Pages: 1809-1817
- Description
  「研究成果報告書概要(欧文)」より
- Data Source
  KAKENHI-PROJECT-18591534
[Journal Article] An essential role of antigen-presenting cell/T-helper type 1 cell-cell interactions in draining lymph node during complete eradication of class II-negative tumor tissue by T-helper type 1 cell therapy.2006
- Author(s)
  Chamoto K, Wakita D, Narita Y, Zhang Y, Noguchi D, Ohnishi H, Iguchi T, Sakai T, Ikeda H, Nishimura T
- Journal Title
  
  Cancer Research 66
  
  Pages: 1809-1817
- Description
  「研究成果報告書概要(和文)」より
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-18591534
[Journal Article] Antitumor activity of chimeric immunoreceptor gene-modified Tc1 and Th1 cells against autologous carcinoembryonic antigen-expressing colon cancer cells2006
- Author(s)
  Sasaki, T, Ikeda, H, Sato, M, Ohkuri, T, Abe, H, Kuroki, M, Onodera, M, Miyamoto, M, Kondo, S, Nishimura, T
- Journal Title
  
  Cancer Science 97
  
  Pages: 920-927
- NAID
  10018767677
- Description
  「研究成果報告書概要(欧文)」より
- Data Source
  KAKENHI-PROJECT-18591534
[Journal Article] lalpha,25-Dihydroxyvitamin D3 downmodulates the functional differentiation of Th1 cytokine-conditioned bone marrow-derived dendritic cells beneficial for cytotoxic T lymphocyte generation2006
- Author(s)
  Matsuzaki, J, Tsuji, T, Zhang, Y, Wakita, D, Imazeki, I, Sakai, T, Ikeda, H, Nishimura, T
- Journal Title
  
  Cancer Science 97
  
  Pages: 139-147
- Description
  「研究成果報告書概要(欧文)」より
- Data Source
  KAKENHI-PROJECT-18591534
[Journal Article] Antitumor activity of chimeric immunoreceptor gene-modified Tcl and Thl cells against autologous carcinoembryonic antigen-expressing colon cancer cells.2006
- Author(s)
  Sasaki T, Ikeda, H, Sato M, Ohkuri T, Abe H, kuroki M, Onodera M, Miyamoto M, Kondo S, Nishimura, T
- Journal Title
  
  Cancer Science 97
  
  Pages: 920-927
- Description
  「研究成果報告書概要(和文)」より
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-18591534
[Journal Article] Expression of the MAGE-A4 and NY-ESO-1 cancer-testis antigens and T cell infiltration in non-small cell lung carcinoma and their prognostic significance2006
- Author(s)
  Yoshida, N, Abe, H, Ohkuri, T, Wakita, D, Sato, M, Noguchi, D, Miyamoto, M, Morikawa, T, Kondo, S, Ikeda, H, Nishimura, T
- Journal Title
  
  International Journal of Oncology 28
  
  Pages: 1089-1098
- Description
  「研究成果報告書概要(欧文)」より
- Data Source
  KAKENHI-PROJECT-18591534
[Journal Article] An indispensable role of type-1 IFNs for inducing CTL-mediated complete eradication of established tumor tissue by CpG-liposome co-encapsulated with model tumor antigen.2006
- Author(s)
  Wakita D, Chamoto K, Zhang Y, Narita Y, Noguchi D, Ohnishi H, Iguchi T, Sakai T, Ikeda H, Nishimura T
- Journal Title
  
  International Immunology 18
  
  Pages: 425-434
- NAID
  10020620780
- Description
  「研究成果報告書概要(和文)」より
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-18591534
[Journal Article] lalpha, 25-Dihydroxyvitamin D3 downmodulates the functional differentiation of Th1 cytokine-conditioned bone marrow-derived dendritic cells beneficial for cytotoxic T lymphocyte generation.2006
- Author(s)
  Matsuzaki J, Tsuii T, Zhang Y, Wakita D, Imazeki I, Sakai T, Ikeda H, Nishimura T
- Journal Title
  
  Cancer Science 97
  
  Pages: 139-147
- Description
  「研究成果報告書概要(和文)」より
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-18591534
[Journal Article] lalpha, 25-Dihydroxyvitamin D3 downmodulates the functional differentiation of Thl cytokine-conditioned bone marrow-derived dendritic cells beneficial for cytotoxic T lymphocyte generation.2006
- Author(s)
  Matsuzaki J, Tsuji T, Zhang Y, Wakita D, Imazeki I, Sakai T, Ikeda H, Nishimura T
- Journal Title
  
  Cancer Science 97
  
  Pages: 139-147
- Data Source
  KAKENHI-PROJECT-18591534
[Journal Article] An essential role of antigen-presenting cell/T-helper type 1 cell-cell interactions in draining Iymph node during complete eradication of class II-negative tumor tissue by T-helper type 1 cell therapy.2006
- Author(s)
  Chamoto K, Wakita D, Narita Y, Zhang Y, Noguchi D, Ohnishi H, Iguchi T, Sakai T, Ikeda H, Nishimura T
- Journal Title
  
  Cancer Research 66
  
  Pages: 1809-1817
- Data Source
  KAKENHI-PROJECT-18591534
[Journal Article] Expression of the MAGE-A4 and NY-ESO-1 cancer-testis antigens and T cell infiltration in non-small cell lung carcinoma and their prognostic significance.2006
- Author(s)
  Yoshida N, Abe H, Ohkuri T, Wakita D, Sato M, Noguchi D, Miyamoto M, Morikawa T, Kondo S, Ikeda H Nishimura T
- Journal Title
  
  International Journal of Oncology 28
  
  Pages: 1089-1098
- Description
  「研究成果報告書概要(和文)」より
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-18591534
[Journal Article] An indispensable role of type-1 IFNs for inducing CTL-mediated complete eradication of established tumor tissue by CpG-liposome co-encapsulated with model tumor antigen2006
- Author(s)
  Wakita, D, Chamoto, K, Zhang, Y, Narita, Y, Noguchi, D, Ohnishi, H, Iguchi, T, Sakai, T, Ikeda, H, Nishimura, T
- Journal Title
  
  International Immunology 18
  
  Pages: 425-434
- NAID
  10020620780
- Description
  「研究成果報告書概要(欧文)」より
- Data Source
  KAKENHI-PROJECT-18591534
[Patent] リンパ球機能亢進剤、リンパ球介在型がん治療法の治療剤との併用剤、及びリンパ球のミトコンドリア機能亢進剤2021
- Inventor(s)
  浅井章良、小郷尚久、池田裕明、村岡大輔、道津洋介、原田直純
- Industrial Property Rights Holder
  静岡県立大学、長崎大学、ユナイテッド・イミュニティ株式会社
- Industrial Property Rights Type
  特許
- Filing Date
  2021
- Data Source
  KAKENHI-PROJECT-21H02990
[Patent] T細胞の機能増強方法2010
- Inventor(s)
  珠玖洋、池田裕明、岩村康一、峰野純一、加藤郁之進
- Industrial Property Rights Holder
  国立大学法人三重大学、タカラバイオ株式会社
- Filing Date
  2010-03-06
- Overseas
- Data Source
  KAKENHI-PROJECT-21591664
[Presentation] Cancer immunotherapy in progress -overview talk-2024
- Author(s)
  Hiroaki Ikeda
- Organizer
  第52回日本免疫学会学術集会
- Invited
- Data Source
  KAKENHI-PROJECT-21H02990
[Presentation] TCR-T therapy combined with ferroptosis inducer overcomes tumor heterogeneity that consists of escape variants2024
- Author(s)
  Daisuke Ehara, Kiyoshi Yasui, Daisuke Muraoka, Hiromitsu Yoneda, Sachiko Okamoto, Yasunori Amaishi, Hiroyuki Murota, Hiroaki Ikeda
- Organizer
  第1回日本がん免疫学会国際がん免疫シンポジウム
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-22K19532
[Presentation] Development of cancer immunotherapy that overcomes tumor heterogeneity2024
- Author(s)
  Hiroaki Ikeda, Daisuke Ehara, Kiyoshi Yasui, Daisuke Muraoka, Hiromitsu Yoneda, Sachiko Okamoto, Yasunori Amaishi, Hiroyuki Murota, Akira Asai
- Organizer
  第1回日本がん免疫学会国際がん免疫シンポジウム
- Invited / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-22K19532
[Presentation] Cancer immunotherapy in progress -overview talk-2024
- Author(s)
  Hiroaki Ikeda
- Organizer
  第52回日本免疫学会学術集会
- Invited
- Data Source
  KAKENHI-PROJECT-22K19532
[Presentation] Development of cancer immunotherapy that overcomes tumor heterogeneity2024
- Author(s)
  Hiroaki Ikeda, Daisuke Ehara, Kiyoshi Yasui, Daisuke Muraoka, Hiromitsu Yoneda, Sachiko Okamoto, Yasunori Amaishi, Hiroyuki Murota, Akira Asai
- Organizer
  第1回日本がん免疫学会国際がん免疫シンポジウム
- Invited / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-21H02990
[Presentation] TCR-T therapy combined with ferroptosis inducer overcomes tumor heterogeneity that consists of escape variants2024
- Author(s)
  Daisuke Ehara, Kiyoshi Yasui, Daisuke Muraoka, Hiromitsu Yoneda, Sachiko Okamoto, Yasunori Amaishi, Hiroyuki Murota, Hiroaki Ikeda
- Organizer
  第1回日本がん免疫学会国際がん免疫シンポジウム
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-21H02990
[Presentation] 固形がんに対するCAR-T細胞療法の開発2023
- Author(s)
  池田裕明
- Organizer
  第33回日本気管食道科学会認定気管食道科専門医大会
- Invited
- Data Source
  KAKENHI-PROJECT-22K19532
[Presentation] 治療標的抗原発現が不均一な腫瘍に対する効果的な細胞輸注療法を担うT細胞の特徴解析と機構解明2023
- Author(s)
  とう思拓, 村岡大輔, 中司交明, 安井潔, 原田直純, 澤田晋一, 秋吉一成, 池田裕明
- Organizer
  第82回日本癌学会学術総会
- Data Source
  KAKENHI-PROJECT-21H02990
[Presentation] 治療標的抗原発現が不均一な腫瘍に対する効果的な細胞輸注療法を担うT細胞の特徴解析と機構解明2023
- Author(s)
  とう思拓, 村岡大輔, 中司交明, 安井潔, 原田直純, 澤田晋一, 秋吉一成, 池田裕明
- Organizer
  第82回日本癌学会学術総会
- Data Source
  KAKENHI-PROJECT-22K19532
[Presentation] 治療標的抗原発現が不均一な腫瘍に対する効果的な細胞輸注療法を担うT細胞の特徴解析と機構解明2023
- Author(s)
  とう思拓, 村岡大輔, 中司交明, 安井潔, 原田直純, 澤田晋一, 秋吉一成, 池田裕明
- Organizer
  第27回日本がん免疫学会総会
- Data Source
  KAKENHI-PROJECT-22K19532
[Presentation] フェロトーシス誘導材を用いた腫瘍不均一性を克服する養子免疫療法の開発2023
- Author(s)
  江原大輔, 安井潔, 村岡大輔, 岡本幸子, 室田浩之, 池田裕明
- Organizer
  第82回日本癌学会学術総会
- Data Source
  KAKENHI-PROJECT-21H02990
[Presentation] 腫瘍不均一性の克服へ向けた新規化合物のスクリーニング2023
- Author(s)
  安井潔, 江原大輔, 岡本幸子, 峰野純一, 村岡大輔, 小郷尚久, 浅井章良, 室田浩之, 池田裕明
- Organizer
  第82回日本癌学会学術総会
- Data Source
  KAKENHI-PROJECT-22K19532
[Presentation] 治療標的抗原発現が不均一な腫瘍に対する効果的な細胞輸注療法を担うT細胞の特徴解析と機構解明2023
- Author(s)
  とう思拓, 村岡大輔, 中司交明, 安井潔, 原田直純, 澤田晋一, 秋吉一成, 池田裕明
- Organizer
  第27回日本がん免疫学会総会
- Data Source
  KAKENHI-PROJECT-21H02990
[Presentation] 腫瘍関連マクロファージ指向性 CHPナノゲルの標的分子の検索2023
- Author(s)
  中司交明, 村田大輔, 安井潔, 原田直純, 澤田晋一, 秋吉一成, 永安武, 池田裕明
- Organizer
  第82回日本癌学会学術総会
- Data Source
  KAKENHI-PROJECT-21H02990
[Presentation] 腫瘍関連マクロファージ指向性 CHPナノゲルの標的分子の検索2023
- Author(s)
  中司交明, 村田大輔, 安井潔, 原田直純, 澤田晋一, 秋吉一成, 碇秀樹, 永安武, 池田裕明
- Organizer
  第27回日本がん免疫学会総会
- Data Source
  KAKENHI-PROJECT-21H02990
[Presentation] 腫瘍関連マクロファージ指向性 CHPナノゲルの標的分子の検索2023
- Author(s)
  中司交明, 村田大輔, 安井潔, 原田直純, 澤田晋一, 秋吉一成, 永安武, 池田裕明
- Organizer
  第82回日本癌学会学術総会
- Data Source
  KAKENHI-PROJECT-22K19532
[Presentation] フェロトーシス現象を利用した養子免疫療法における腫瘍内不均一性の克服2023
- Author(s)
  江原大輔, 安井潔, 村岡大輔, 岡本幸子, 池田裕明
- Organizer
  第27回日本がん免疫学会総会
- Data Source
  KAKENHI-PROJECT-21H02990
[Presentation] 腫瘍不均一性の克服へ向けた新規化合物のスクリーニング2023
- Author(s)
  安井潔, 江原大輔, 岡本幸子, 峰野純一, 村岡大輔, 小郷尚久, 浅井章良, 室田浩之, 池田裕明
- Organizer
  第27回日本がん免疫学会総会
- Data Source
  KAKENHI-PROJECT-21H02990
[Presentation] 固形がんに対するCAR-T細胞療法の開発2023
- Author(s)
  池田裕明
- Organizer
  第33回日本気管食道科学会認定気管食道科専門医大会
- Invited
- Data Source
  KAKENHI-PROJECT-21H02990
[Presentation] フェロトーシス誘導材を用いた腫瘍不均一性を克服する養子免疫療法の開発2023
- Author(s)
  江原大輔, 安井潔, 村岡大輔, 岡本幸子, 室田浩之, 池田裕明
- Organizer
  第82回日本癌学会学術総会
- Data Source
  KAKENHI-PROJECT-22K19532
[Presentation] 腫瘍関連マクロファージ指向性CHPナノゲルの標的分子の探索2023
- Author(s)
  中司交明、村岡大輔、安井潔、原田直純、澤田晋一、秋吉一成、永安武、池田裕明
- Organizer
  第82回日本癌学会学術総会 (横浜)
- Data Source
  KAKENHI-PROJECT-21H03005
[Presentation] 治療標的抗原発現が不均一な腫瘍に対する効果的な細胞輸注療法を担うT細胞の特徴解析と機構解明2023
- Author(s)
  とう思拓、村岡大輔、中司交明、安井潔、原田直純、澤田晋一、秋吉一成、池田裕明
- Organizer
  第82回日本癌学会学術総会 (横浜)
- Data Source
  KAKENHI-PROJECT-21H03005
[Presentation] 腫瘍関連マクロファージ指向性 CHPナノゲルの標的分子の検索2023
- Author(s)
  中司交明, 村田大輔, 安井潔, 原田直純, 澤田晋一, 秋吉一成, 碇秀樹, 永安武, 池田裕明
- Organizer
  第27回日本がん免疫学会総会
- Data Source
  KAKENHI-PROJECT-22K19532
[Presentation] フェロトーシス現象を利用した養子免疫療法における腫瘍内不均一性の克服2023
- Author(s)
  江原大輔, 安井潔, 村岡大輔, 岡本幸子, 池田裕明
- Organizer
  第27回日本がん免疫学会総会
- Data Source
  KAKENHI-PROJECT-22K19532
[Presentation] 腫瘍不均一性の克服へ向けた新規化合物のスクリーニング2023
- Author(s)
  安井潔, 江原大輔, 岡本幸子, 峰野純一, 村岡大輔, 小郷尚久, 浅井章良, 室田浩之, 池田裕明
- Organizer
  第82回日本癌学会学術総会
- Data Source
  KAKENHI-PROJECT-21H02990
[Presentation] 腫瘍不均一性の克服へ向けた新規化合物のスクリーニング2023
- Author(s)
  安井潔, 江原大輔, 岡本幸子, 峰野純一, 村岡大輔, 小郷尚久, 浅井章良, 室田浩之, 池田裕明
- Organizer
  第27回日本がん免疫学会総会
- Data Source
  KAKENHI-PROJECT-22K19532
[Presentation] 腫瘍不均一性の克服に向けた「ステルス T 細胞」を用いたがん免疫療法の開発2022
- Author(s)
  安井潔, 岡田怜美, 江原大輔, 岡本幸子, 峰野純一, 村岡大輔, 江口晋, 池田裕明
- Organizer
  第81回日本癌学会総会
- Data Source
  KAKENHI-PROJECT-21H02990
[Presentation] 免疫細胞死誘導剤(IDI)による腫瘍不均一性を克服する養子免疫療法の開発2022
- Author(s)
  江原大輔, 山口小百合, 安井潔, 村岡大輔, 岡本幸子, 峰野純一, 室田浩之, 池田裕明
- Organizer
  第81回日本癌学会総会
- Data Source
  KAKENHI-PROJECT-21H02990
[Presentation] CHPナノゲルの標的分子の検索と、腫瘍関連マクロファージを標的とする新規免疫慮法の開発2022
- Author(s)
  中司交明, 村田大輔, 安井潔, 原田直純, 澤田晋一, 秋吉一成, 永安武, 池田裕明
- Organizer
  第26回日本がん免疫学会総会
- Data Source
  KAKENHI-PROJECT-21H02990
[Presentation] NY-ESO-1/TCR-T細胞輸注後のサイトカイン放出症候群に関連するT細胞特性2022
- Author(s)
  影山慎一, 宮原慶裕, 石原幹也, 岡本幸子, 戸村大介, 糠谷育衛, 蝶野英人, 峰野純一, 渡辺隆, 池田裕明, 珠玖洋
- Organizer
  第26回日本がん免疫学会総会
- Data Source
  KAKENHI-PROJECT-22K19532
[Presentation] ミトコンドリア電子伝達系を介してT細胞の活性化閾値を改善する新基軸代謝化合物を用いたがん免疫療法の開発2022
- Author(s)
  道津洋介, 村岡大輔, 園田祐大, 小郷尚久, 浅井章良, 八木田秀雄, 迎寛, 池田裕明
- Organizer
  第26回日本がん免疫学会総会
- Data Source
  KAKENHI-PROJECT-21H02990
[Presentation] CHP-NY-ESO-1の臨床効果とPIGR遺伝子発現および抗原特異的IgAの関連-食道癌術後補助がんワクチン臨床試験の探索的研究より-2022
- Author(s)
  永田康浩, 影山慎一, 宮原慶裕, 山田知美, 大佐古昌治, 宮本博, 渡辺隆, 池田裕明, 珠玖洋
- Organizer
  第26回日本がん免疫学会総会
- Data Source
  KAKENHI-PROJECT-22K19532
[Presentation] ミトコンドリア電子伝達系活性化合物は腫瘍浸潤 T 細胞の活性化閾値を改善し抗腫瘍効果を導く2022
- Author(s)
  村岡大輔, 道津洋介, 小郷尚久, 園田雄大, 八木田秀雄, 松下和博, 浅井章良, 池田裕明
- Organizer
  第81回日本癌学会総会
- Data Source
  KAKENHI-PROJECT-22K19532
[Presentation] Harnessing TCR-T therapy to overcome personalization and tumor heterogeneity2022
- Author(s)
  池田裕明
- Organizer
  第28回日本遺伝子細胞治療学会学術集会
- Invited
- Data Source
  KAKENHI-PROJECT-21H02990
[Presentation] 免疫細胞死誘導剤(IDI)による腫瘍不均一性を克服する養子免疫療法の開発2022
- Author(s)
  江原大輔, 山口小百合, 安井潔, 村岡大輔, 岡本幸子, 峰野純一, 室田浩之, 池田裕明
- Organizer
  第81回日本癌学会総会
- Data Source
  KAKENHI-PROJECT-22K19532
[Presentation] がん免疫療法における腫瘍関連マクロファージを標的とする DDS である「CHP ナノゲル」の標的分子の同定2022
- Author(s)
  中司交明, 村岡大輔, 安井潔, 原田直純, 澤田晋一, 秋吉一成, 永安武, 池田裕明
- Organizer
  第81回日本癌学会総会
- Data Source
  KAKENHI-PROJECT-22K19532
[Presentation] CHP-NY-ESO-1の臨床効果とPIGR遺伝子発現および抗原特異的IgAの関連-食道癌術後補助がんワクチン臨床試験の探索的研究より-2022
- Author(s)
  永田康浩, 影山慎一, 宮原慶裕, 山田知美, 大佐古昌治, 宮本博, 渡辺隆, 池田裕明, 珠玖洋
- Organizer
  第26回日本がん免疫学会総会
- Data Source
  KAKENHI-PROJECT-21H02990
[Presentation] Development of adoptive T cell therapy for cancer patients utilizing humanized mice.2022
- Author(s)
  池田裕明
- Organizer
  第6回ヒト化マウス国際ワークショップ
- Invited / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-22K19532
[Presentation] Harnessing TCR-T therapy to overcome personalization and tumor heterogeneity2022
- Author(s)
  池田裕明
- Organizer
  第28回日本遺伝子細胞治療学会学術集会
- Invited
- Data Source
  KAKENHI-PROJECT-22K19532
[Presentation] NY-ESO-1/TCR-T細胞輸注後のサイトカイン放出症候群に関連するT細胞特性2022
- Author(s)
  影山慎一, 宮原慶裕, 石原幹也, 岡本幸子, 戸村大介, 糠谷育衛, 蝶野英人, 峰野純一, 渡辺隆, 池田裕明, 珠玖洋
- Organizer
  第26回日本がん免疫学会総会
- Data Source
  KAKENHI-PROJECT-21H02990
[Presentation] Development of adoptive T cell therapy for cancer patients utilizing humanized mice.2022
- Author(s)
  池田裕明
- Organizer
  第6回ヒト化マウス国際ワークショップ
- Invited / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-21H02990
[Presentation] 腫瘍不均一性の克服へ向けた「ステルスT細胞」を用いたがん免疫療法の開発2022
- Author(s)
  安井潔, 岡田怜美, 江原大輔, 魚谷周平, 森爽太, 岡本幸子, 峰野純一, 村岡大輔, 江口晋, 室田浩之, 池田裕明
- Organizer
  第26回日本がん免疫学会総会
- Data Source
  KAKENHI-PROJECT-21H02990
[Presentation] ミトコンドリア電子伝達系を介してT細胞の活性化閾値を改善する新基軸代謝化合物を用いたがん免疫療法の開発2022
- Author(s)
  道津洋介, 村岡大輔, 園田祐大, 小郷尚久, 浅井章良, 八木田秀雄, 迎寛, 池田裕明
- Organizer
  第26回日本がん免疫学会総会
- Data Source
  KAKENHI-PROJECT-22K19532
[Presentation] ミトコンドリア電子伝達系活性化合物は腫瘍浸潤 T 細胞の活性化閾値を改善し抗腫瘍効果を導く2022
- Author(s)
  村岡大輔, 道津洋介, 小郷尚久, 園田雄大, 八木田秀雄, 松下和博, 浅井章良, 池田裕明
- Organizer
  第81回日本癌学会総会
- Data Source
  KAKENHI-PROJECT-21H02990
[Presentation] 腫瘍不均一性の克服に向けた「ステルス T 細胞」を用いたがん免疫療法の開発2022
- Author(s)
  安井潔, 岡田怜美, 江原大輔, 岡本幸子, 峰野純一, 村岡大輔, 江口晋, 池田裕明
- Organizer
  第81回日本癌学会総会
- Data Source
  KAKENHI-PROJECT-22K19532
[Presentation] CHPナノゲルの標的分子の検索と、腫瘍関連マクロファージを標的とする新規免疫慮法の開発2022
- Author(s)
  中司交明, 村田大輔, 安井潔, 原田直純, 澤田晋一, 秋吉一成, 永安武, 池田裕明
- Organizer
  第26回日本がん免疫学会総会
- Data Source
  KAKENHI-PROJECT-22K19532
[Presentation] Exploring the molecules involving in the drug delivery targeted to tumor-associated macrophages by CHP nanogels2022
- Author(s)
  中司交明、村岡大輔、安井潔、原田直純、澤田晋一、秋吉一成、永安武、池田裕明
- Organizer
  第81回日本癌学会学術総会
- Data Source
  KAKENHI-PROJECT-21H03005
[Presentation] がん免疫療法における腫瘍関連マクロファージを標的とする DDS である「CHP ナノゲル」の標的分子の同定2022
- Author(s)
  中司交明, 村岡大輔, 安井潔, 原田直純, 澤田晋一, 秋吉一成, 永安武, 池田裕明
- Organizer
  第81回日本癌学会総会
- Data Source
  KAKENHI-PROJECT-21H02990
[Presentation] 腫瘍不均一性の克服へ向けた「ステルスT細胞」を用いたがん免疫療法の開発2022
- Author(s)
  安井潔, 岡田怜美, 江原大輔, 魚谷周平, 森爽太, 岡本幸子, 峰野純一, 村岡大輔, 江口晋, 室田浩之, 池田裕明
- Organizer
  第26回日本がん免疫学会総会
- Data Source
  KAKENHI-PROJECT-22K19532
[Presentation] フェロトーシス誘導剤を用いた腫瘍不均一性を克服するがん免疫療法の開発2021
- Author(s)
  江原大輔、山口小百合、安井潔、村岡大輔、室田浩之、池田裕明
- Organizer
  第25回日本がん免疫学会
- Data Source
  KAKENHI-PROJECT-19K09048
[Presentation] Development of novel adoptive cell therapy for the heterogeneous tumor via antigen-independent tumor-killing2021
- Author(s)
  Situo Deng, Daisuke Muraoka, Hiroaki Ikeda
- Organizer
  第80回日本癌学会学術総会
- Data Source
  KAKENHI-PROJECT-21H03005
[Presentation] HANG cancer vaccine rejects anti PD-1 therapy resistant-tumor via potent neoantigen-specific CTL in draining lymph node2021
- Author(s)
  百瀬文康,中井貴士,白木広治,福本圭介,勝又徹,藪内昂平,村岡大輔,池田裕明,珠玖洋
- Organizer
  第８０回日本癌学会
- Data Source
  KAKENHI-PROJECT-21H02990
[Presentation] 独自siRNAベクターによるMHC classⅠ発現抑制「ステルスT細胞」を用いたがん免疫療法の開発2021
- Author(s)
  安井　潔、Xiangyue Meng、岡田怜美、岡本幸子、峰野純一、村岡大輔、珠玖　洋、江口　晋、池田裕明
- Organizer
  がん免疫学会
- Data Source
  KAKENHI-PROJECT-19K09048
[Presentation] 非自己のリンパ球を用いたがん免疫療法の開発2021
- Author(s)
  池田裕明
- Organizer
  第29回日本組織適合性学会大会
- Invited
- Data Source
  KAKENHI-PROJECT-21H02990
[Presentation] ヒアルロン酸ナノゲルワクチンとTCR-T細胞併用は所属リンパ節で強力に腫瘍抗原特異的CTLを誘導し、抗PD-1抵抗性腫瘍を消失させる2021
- Author(s)
  百瀬文康,中井貴士,白木広治,福本圭介,勝又徹,藪内昴平,村岡大輔,林妙,池田裕明,珠玖洋
- Organizer
  第25回日本がん免疫学会総会
- Data Source
  KAKENHI-PROJECT-21H02990
[Presentation] The compound activating mitochondrial respiration leads PD-1 blockade efficacy even in a low immunogenic tumor2021
- Author(s)
  道津洋介,村岡大輔,園田祐大,小郷尚久,浅井章良,八木田秀雄,迎寛,池田裕明
- Organizer
  第８０回日本癌学会
- Data Source
  KAKENHI-PROJECT-21H02990
[Presentation] 独自siRNAベクターによるMHC class Ⅰ発現抑制「ステルスT細胞」を用いたがん免疫療法の開発2021
- Author(s)
  安井潔,MENG xiangyue,岡田怜美,岡本幸子,峰野純一,村岡大輔,珠玖洋,江口晋,池田裕明
- Organizer
  第25回日本がん免疫学会総会
- Data Source
  KAKENHI-PROJECT-21H02990
[Presentation] Development of novel adoptive cell therapy for the heterogeneous tumor via antigen-independent tumor-killing2021
- Author(s)
  鄧思拓,村岡大輔,池田裕明
- Organizer
  第８０回日本癌学会
- Data Source
  KAKENHI-PROJECT-21H02990
[Presentation] 独自siRNAベクターによるMHC class I発現抑制「ステルスT細胞」を用いたがん免疫療法の開発2021
- Author(s)
  安井潔、MENG X、岡田怜美、岡本幸子、峰野純一、村岡大輔、珠玖洋、江口晋、池田裕明
- Organizer
  第25回日本がん免疫学会
- Data Source
  KAKENHI-PROJECT-19K09048
[Presentation] Cancer immunotherapy that overcomes tumor heterogeneity utilizing ferroptosis2021
- Author(s)
  江原大輔,山口小百合,安井潔,村岡大輔,室田浩之,池田裕明
- Organizer
  第８０回日本癌学会
- Data Source
  KAKENHI-PROJECT-21H02990
[Presentation] フェロトーシス現象を利用した腫瘍不均一性を克服するがん免疫療法2021
- Author(s)
  江原大輔、山口小百合、安井潔、村岡大輔、室田浩之、池田裕明
- Organizer
  第80回日本癌学会
- Data Source
  KAKENHI-PROJECT-19K09048
[Presentation] フェロトーシス誘導材を用いた腫瘍不均一性を克服するがん免疫療法の開発2021
- Author(s)
  江原大輔, 山口小百合,安井潔,村岡大輔,室田浩之,池田裕明
- Organizer
  第25回日本がん免疫学会総会
- Data Source
  KAKENHI-PROJECT-21H02990
[Presentation] Exploring the molucule involving in the antigen delivery targeted to tumor-associated macrophages2021
- Author(s)
  中司交明,村岡大輔,鄧思拓,道津洋介,安井潔,澤田晋一,秋吉一成,池田裕明
- Organizer
  第８０回日本癌学会
- Data Source
  KAKENHI-PROJECT-21H02990
[Presentation] 低分子化合物によるミトコンドリア機能の制御は、不十分な抗原刺激下におけるT細胞をも活性化し、抗PD-1抗体療法の有効性を導く2021
- Author(s)
  道津洋介,村岡大輔,園田祐大,小郷尚久,浅井章良,八木田秀雄,迎寛,池田裕明
- Organizer
  第25回日本がん免疫学会総会
- Data Source
  KAKENHI-PROJECT-21H02990
[Presentation] TCR-T細胞療法の臨床開発2021
- Author(s)
  池田裕明
- Organizer
  第８０回日本癌学会
- Invited
- Data Source
  KAKENHI-PROJECT-21H02990
[Presentation] Low molecular weight compound enhancing tumor antigen recognition through the augmentation of NF-kB signaling boosts tumor antigen-specific T cell infusion therapy.2020
- Author(s)
  Yosuke Dotsu, Daisuke Muraoka, Yudai Sonoda , Akira Asai , Hiroshi Mukae , Hiroaki Ikeda
- Organizer
  第24回日本がん免疫学会総会
- Data Source
  KAKENHI-PROJECT-18H02872
[Presentation] 遺伝子改変T細胞療法の新展開2020
- Author(s)
  池田裕明
- Organizer
  第79回日本癌学会学術総会
- Invited
- Data Source
  KAKENHI-PROJECT-18K19584
[Presentation] 遺伝子改変T細胞療法の新展開2020
- Author(s)
  池田裕明
- Organizer
  第79回日本癌学会学術総会
- Invited
- Data Source
  KAKENHI-PROJECT-18H02872
[Presentation] Low molecular weight compound enhancing tumor antigen recognition through the augmentation of NF-kB signaling boosts tumor antigen-specific T cell infusion therapy.2020
- Author(s)
  Yosuke Dotsu, Daisuke Muraoka, Yudai Sonoda , Akira Asai , Hiroshi Mukae , Hiroaki Ikeda
- Organizer
  第24回日本がん免疫学会総会
- Data Source
  KAKENHI-PROJECT-18K19584
[Presentation] TCR遺伝子導入T細胞輸注療法の開発2020
- Author(s)
  池田裕明
- Organizer
  第19回日本再生医療学会総会
- Invited
- Data Source
  KAKENHI-PROJECT-18H02872
[Presentation] T細胞やNK細胞による拒絶反応、およびGVHDを回避しうる「ステルスT細胞」を用いたがん免疫療法の開発2020
- Author(s)
  安井　潔、岡田怜美、岡本幸子、峰野純一、村岡大輔、珠玖　洋、江口　晋、池田裕明
- Organizer
  がん免疫学会
- Data Source
  KAKENHI-PROJECT-19K09048
[Presentation] T細胞やNK細胞による拒絶反応、およびGVHDを回避しうる「ステルスT細胞」を用いたがん免疫療法の開発2020
- Author(s)
  安井潔、岡田怜美、岡本幸子、峰野純一、村岡大輔、珠玖洋、江口晋、池田裕明
- Organizer
  がん免疫学会
- Data Source
  KAKENHI-PROJECT-19K09048
[Presentation] 教育セッション・がん研究入門コース　「癌免疫細胞療法の基礎と臨床」2020
- Author(s)
  池田裕明
- Organizer
  第79回日本癌学会学術総会
- Invited
- Data Source
  KAKENHI-PROJECT-18H02872
[Presentation] Immune-related adverse events induced by T-cell adoptive immunotherapy using genetically engineered TCR-T cells.2020
- Author(s)
  HIROAKI IKEDA
- Organizer
  米国毒性学会2020学術総会
- Invited / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-18K19584
[Presentation] 教育セッション・がん研究入門コース「癌免疫細胞療法の基礎と臨床」2020
- Author(s)
  池田裕明
- Organizer
  第79回日本癌学会学術総会
- Invited
- Data Source
  KAKENHI-PROJECT-18K19584
[Presentation] T細胞やNK細胞による拒絶反応、およびGVHDを回避しうる「ステルスT細胞」を用いたがん免疫療法の開発2020
- Author(s)
  Kiyoshi Yasui, Satomi Okada, Sachiko Okamoto, Junichi Mineno, Daisuke Muraoka , Hiroshi Shiku, Susumu Eguchi, Hiroaki Ikeda.
- Organizer
  第24回日本がん免疫学会総会
- Invited
- Data Source
  KAKENHI-PROJECT-18K19584
[Presentation] がん免疫療法の挑戦～免疫チェックポイント阻害療法、細胞療法、そしてその先へ～2020
- Author(s)
  池田裕明
- Organizer
  佐賀がん免疫療法セミナー
- Invited
- Data Source
  KAKENHI-PROJECT-18H02872
[Presentation] がん免疫療法の挑戦 ~免疫チェックポイント阻害療法、細胞療法、そしてその先へ~2020
- Author(s)
  池田裕明
- Organizer
  佐賀がん免疫療法セミナー
- Invited
- Data Source
  KAKENHI-PROJECT-18K19584
[Presentation] 遺伝子改変 T 細胞療法の新展開2020
- Author(s)
  池田裕明
- Organizer
  日本癌学会
- Invited
- Data Source
  KAKENHI-PROJECT-19K09048
[Presentation] Immune-related adverse events induced by T-cell adoptive immunotherapy using genetically engineered TCR-T cells2020
- Author(s)
  HIROAKI IKEDA
- Organizer
  米国毒性学会2020学術総会
- Invited / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-18H02872
[Presentation] TCR遺伝子導入T細胞輸注療法の開発2020
- Author(s)
  池田裕明
- Organizer
  第19回日本再生医療学会総会
- Invited
- Data Source
  KAKENHI-PROJECT-18K19584
[Presentation] T細胞やNK細胞による拒絶反応、およびGVHDを回避しうる「ステルスT細胞」を用いたがん免疫療法の開発2020
- Author(s)
  Kiyoshi Yasui, Satomi Okada, Sachiko Okamoto, Junichi Mineno, Daisuke Muraoka , Hiroshi Shiku, Susumu Eguchi, Hiroaki Ikeda
- Organizer
  第24回日本がん免疫学会総会
- Invited
- Data Source
  KAKENHI-PROJECT-18H02872
[Presentation] 非自己T細胞の利用を可能にする「ステルスT細胞」を用いたがん免疫療法の開発2019
- Author(s)
  安井潔、岡田怜美、松村尚美、古賀洋一、岡本幸子、峰野純一、村岡大輔、珠玖洋、江口晋、池田裕明
- Organizer
  第23回日本がん免疫学会総会
- Data Source
  KAKENHI-PROJECT-18K19584
[Presentation] 低分子化合物による抗原認識能の向上作用の機構解明と大腸癌マウスモデルにおける腫瘍浸潤T細胞への影響の解析2019
- Author(s)
  Yosuke Dotsu, Daisuke Muraoka, Yudai Sonoda, Akira Asai, Hiroshi Mukae, Hiroaki Ikeda
- Organizer
  第78回日本癌学会学術集会
- Data Source
  KAKENHI-PROJECT-18K19584
[Presentation] TCR遺伝子導入T細胞を用いたがん免疫細胞治療2019
- Author(s)
  池田裕明
- Organizer
  日本輸血・細胞治療学会
- Data Source
  KAKENHI-PROJECT-19K09048
[Presentation] 低分子化合物による抗原認識能の向上作用の機構解明と大腸癌マウスモデルにおける腫瘍浸潤T細胞への影響の解析2019
- Author(s)
  Yosuke Dotsu, Daisuke Muraoka, Yudai Sonoda, Akira Asai, Hiroshi Mukae, Hiroaki Ikeda.
- Organizer
  第78回日本癌学会学術総会
- Data Source
  KAKENHI-PROJECT-18H02872
[Presentation] Development of novel adoptive immunotherapy of cancer with gene-engineered T cells.2019
- Author(s)
  Hiroaki Ikeda
- Organizer
  長崎大学・ライデン大学国際シンポジウム
- Invited / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-18H02872
[Presentation] Development of Adoptive Cell Therapy with Allogeneic TCR Gene-modified “Stealth T cells” Deficient in Endogenous TCR and HLA Class I Molecules2019
- Author(s)
  Hiroaki Ikeda, Satomi Okada, Yoichi Koga, Daisuke Muraoka, Kiyoshi Yasui, Sachiko Okamoto, Junichi Mineno, Hiroshi Shiku, Susumu Eguchi
- Organizer
  日本血液学会国際シンポジウム
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-18K19584
[Presentation] TCR遺伝子導入T細胞を用いたがん免疫細胞治療2019
- Author(s)
  池田裕明
- Organizer
  第67回日本輸血・細胞治療学会
- Invited
- Data Source
  KAKENHI-PROJECT-18K19584
[Presentation] TCR遺伝子導入T細胞を用いたがん免疫細胞治療2019
- Author(s)
  池田裕明
- Organizer
  第67回日本輸血・細胞治療学会
- Invited
- Data Source
  KAKENHI-PROJECT-18H02872
[Presentation] Development of novel adoptive immunotherapy of cancer with gene-engineered T cells2019
- Author(s)
  Hiroaki Ikeda
- Organizer
  長崎大学・ライデン大学国際シンポジウム
- Invited / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-18K19584
[Presentation] 抗原性を消失させた肝細胞/肝癌細胞シート作製の試み2019
- Author(s)
  岡田怜美、高槻光寿、堺裕輔、日高匡章、足立智彦、大野慎一郎、夏田孔史、濱田隆志、前川恭一郎、池田裕明、江口晋、
- Organizer
  第119回日本外科学会定期学術集会
- Data Source
  KAKENHI-PROJECT-17K10516
[Presentation] PCR法によるMAGE-A4、NY-ESO-1およびSAGE抗原の腫瘍組織における発現2019
- Author(s)
  Mikiya Ishihara, Shinichi Kageyama, Yoshihiro Miyahara, Takeshi Ishikawa, Shugo Ueda, Norihito Soga, Hiroaki Ikeda, Hiroshi Shiku.
- Organizer
  第78回日本癌学会学術集会
- Data Source
  KAKENHI-PROJECT-18H02872
[Presentation] 個別化T細胞療法の開発2019
- Author(s)
  池田裕明
- Organizer
  第23回日本がん免疫学会総会
- Invited
- Data Source
  KAKENHI-PROJECT-18K19584
[Presentation] 遺伝子改変T細胞　ーがんに対する免疫細胞療法の幕開けー2019
- Author(s)
  池田裕明
- Organizer
  長崎大学第二内科学会
- Invited
- Data Source
  KAKENHI-PROJECT-18H02872
[Presentation] Development of Adoptive Cell Therapy with Allogeneic TCR Gene-modified “Stealth T cells” Deficient in Endogenous TCR and HLA Class I Molecules2019
- Author(s)
  池田裕明
- Organizer
  The 10th JSH International Symposium
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-19K09048
[Presentation] 個別化T細胞療法の開発2019
- Author(s)
  池田裕明
- Organizer
  第23回日本がん免疫学会総会
- Invited
- Data Source
  KAKENHI-PROJECT-18H02872
[Presentation] 新規TCR遺伝子改変T細胞療法の臨床開発2019
- Author(s)
  池田裕明
- Organizer
  第2回 AMED/A*STAR 合同ワークショップ
- Invited / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-18K19584
[Presentation] 低分子化合物による抗原認識能の向上作用の機構解明と大腸癌マウスモデルにおける腫瘍浸潤T細胞への影響の解析2019
- Author(s)
  道津洋介、村岡大輔、園田祐大、浅井章良、迎　寛、池田裕明
- Organizer
  第23回日本がん免疫学会総会
- Data Source
  KAKENHI-PROJECT-18H02872
[Presentation] がん免疫療法の新展開~遺伝子改変T細胞療法の開発~2019
- Author(s)
  池田裕明
- Organizer
  Kumamoto Dermatology Exhaustive Seminar
- Invited
- Data Source
  KAKENHI-PROJECT-18K19584
[Presentation] 遺伝子改変T細胞ーがんに対する免疫細胞療法の幕開けー2019
- Author(s)
  池田裕明
- Organizer
  長崎大学第二内科学会
- Invited
- Data Source
  KAKENHI-PROJECT-18K19584
[Presentation] 低分子化合物による抗原認識能の向上作用の機構解明と大腸癌マウスモデルにおける腫瘍浸潤T細胞への影響の解析2019
- Author(s)
  道津洋介、村岡大輔、園田祐大、浅井章良、迎寛、池田裕明
- Organizer
  第23回日本がん免疫学会総会
- Data Source
  KAKENHI-PROJECT-18K19584
[Presentation] PCR法によるMAGE-A4、NY-ESO-1およびSAGE抗原の腫瘍組織における発現2019
- Author(s)
  Mikiya Ishihara, Shinichi Kageyama, Yoshihiro Miyahara, Takeshi Ishikawa, Shugo Ueda, Norihito Soga, Hiroaki Ikeda, Hiroshi Shiku
- Organizer
  第78回日本癌学会学術集会
- Data Source
  KAKENHI-PROJECT-18K19584
[Presentation] がん免疫療法の新展開～遺伝子改変T細胞療法の開発～2019
- Author(s)
  池田裕明
- Organizer
  Kumamoto Dermatology Exhaustive Seminar
- Invited
- Data Source
  KAKENHI-PROJECT-18H02872
[Presentation] Development of Adoptive Cell Therapy with Allogeneic TCR Gene-modified “Stealth T cells” Deficient in Endogenous TCR and HLA Class I Molecules.2019
- Author(s)
  Hiroaki Ikeda, Satomi Okada, Yoichi Koga, Daisuke Muraoka, Kiyoshi Yasui, Sachiko Okamoto, Junichi Mineno, Hiroshi Shiku, Susumu Eguchi.
- Organizer
  日本血液学会国際シンポジウム
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-18H02872
[Presentation] 非自己T細胞の利用を可能にする「ステルスT細胞」を用いたがん免疫療法の開発2019
- Author(s)
  安井　潔、岡田怜美、松村尚美、古賀洋一、岡本幸子、峰野純一、村岡大輔、珠玖　洋、江口　晋、池田裕明
- Organizer
  第23回日本がん免疫学会総会
- Data Source
  KAKENHI-PROJECT-18H02872
[Presentation] 成人T細胞白血病に対する新規HTLV-1 p40Tax特異的TCR遺伝子導入同種γ/δ-T細胞輸注療法の開発研究2019
- Author(s)
  藤原弘、奥村悟司、藤井啓介、宮原慶裕、俵功、城達郎、田中義正、池田裕明、珠玖洋
- Organizer
  第23回日本がん免疫学会総会
- Data Source
  KAKENHI-PROJECT-18K19584
[Presentation] 新規TCR遺伝子改変T細胞療法の臨床開発2019
- Author(s)
  池田裕明
- Organizer
  第2回 AMED/A*STAR 合同ワークショップ
- Invited / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-19K09048
[Presentation] 成人T細胞白血病に対する新規HTLV-1 p40Tax特異的TCR遺伝子導入同種γ/δ-T細胞輸注療法の開発研究2019
- Author(s)
  藤原　弘、奥村悟司、藤井啓介、宮原慶裕、俵　功、城　達郎、田中義正、池田裕明、,珠玖　洋
- Organizer
  第23回日本がん免疫学会総会
- Data Source
  KAKENHI-PROJECT-18H02872
[Presentation] 非自己Ｔ細胞の利用を可能にするステルスＴ細胞を用いたがん免疫療法の開発2019
- Author(s)
  安井潔、岡田怜美、松村尚美、古賀洋一、岡本幸子、峰野純一、村岡大輔、珠玖　洋、江口　晋、池田裕明
- Organizer
  がん免疫学会
- Data Source
  KAKENHI-PROJECT-19K09048
[Presentation] 腫瘍の細胞性免疫応答反応性を規定するマクロファージの分化機構の解明2018
- Author(s)
  村岡大輔, 瀬尾尚宏, 林妙, 藤井啓介, 池田裕明, 秋吉一成, 原田直純, 珠玖　洋
- Organizer
  第22回日本がん免疫学会総会
- Data Source
  KAKENHI-PROJECT-18H02872
[Presentation] がん特異的T細胞を用いた細胞療法の開発2018
- Author(s)
  池田裕明
- Organizer
  第22回日本がん免疫学会総会
- Invited
- Data Source
  KAKENHI-PROJECT-18H02872
[Presentation] Adoptive therapy with TCR-gene modified T cells for the treatment of patients with hematological malignancy and solid tumors2018
- Author(s)
  池田裕明
- Organizer
  第８０回日本血液学会学術集会
- Invited
- Data Source
  KAKENHI-PROJECT-18H02872
[Presentation] 有望な遺伝子改変γδ T細胞を用いたがん免疫療法2018
- Author(s)
  奥村悟司, 加藤琢磨, Wang Yizheng, 林妙, 白倉和子, 池田裕明, 王立楠, 宮原慶裕, 田中義正, 珠玖洋
- Organizer
  第77回日本癌学会学術総会
- Data Source
  KAKENHI-PROJECT-18K19584
[Presentation] 内因性TCRおよびMHC発現の抑制により非自己T細胞の利用を可能にしたT細胞輸注療法の開発2018
- Author(s)
  岡田怜美、安井　潔、岡本幸子、峰野純一、竹迫一任、珠玖　洋、江口　晋、池田裕明
- Organizer
  第22回日本がん免疫学会総会
- Data Source
  KAKENHI-PROJECT-18H02872
[Presentation] がんに対するT細胞の輸注療法の臨床開発2018
- Author(s)
  池田裕明
- Organizer
  第12回InVivo実験医学シンポジウム
- Invited
- Data Source
  KAKENHI-PROJECT-18H02872
[Presentation] 腫瘍におけるNY-ESO-1発現と抗体反応はMAGE-A4ワクチン療法を受ける食道・頭頸部癌患者の予後不良を示す2018
- Author(s)
  上田修吾, 宮原慶裕, 永田康浩, 佐藤永一, 池田裕明, 原田直純, 珠玖洋, 影山慎一
- Organizer
  第77回日本癌学会学術総会
- Data Source
  KAKENHI-PROJECT-18K19584
[Presentation] 造血器腫瘍に対する免疫細胞療法の開発2018
- Author(s)
  池田裕明
- Organizer
  第39回久留米造血器腫瘍研究会
- Invited
- Data Source
  KAKENHI-PROJECT-18K19584
[Presentation] 有望な遺伝子改変γδ T細胞を用いたがん免疫療法2018
- Author(s)
  奥村悟司, 加藤琢磨, Wang Yizheng, 林妙, 白倉和子, 池田裕明, 王立楠, 宮原慶裕, 田中義正, 珠玖洋
- Organizer
  第77回日本癌学会学術総会
- Data Source
  KAKENHI-PROJECT-18H02872
[Presentation] 腫瘍におけるNY-ESO-1発現と抗体反応はMAGE-A4ワクチン療法を受ける食道・頭頸部癌患者の予後不良を示す2018
- Author(s)
  上田修吾, 宮原慶裕, 永田康浩, 佐藤永一, 池田裕明, 原田直純, 珠玖洋, 影山慎一
- Organizer
  第77回日本癌学会学術総会
- Data Source
  KAKENHI-PROJECT-18H02872
[Presentation] Adoptive therapy with TCR-gene modified T cells for the treatment of patients with hematological malignancy and solid tumors2018
- Author(s)
  池田裕明
- Organizer
  第80回日本血液学会学術集会(招待講演)
- Invited
- Data Source
  KAKENHI-PROJECT-18K19584
[Presentation] がんに対するT細胞の輸注療法の臨床開発2018
- Author(s)
  池田裕明
- Organizer
  第12回InVivo実験医学シンポジウム
- Invited
- Data Source
  KAKENHI-PROJECT-18K19584
[Presentation] 造血器腫瘍および固形腫瘍に対するTCR遺伝子導入リンパ球輸注療法の開発2018
- Author(s)
  池田裕明
- Organizer
  第22回日本がん免疫学会総会
- Invited
- Data Source
  KAKENHI-PROJECT-18H02872
[Presentation] がん特異的T細胞を用いた細胞療法の開発2018
- Author(s)
  池田裕明
- Organizer
  第22回日本がん免疫学会総会
- Invited
- Data Source
  KAKENHI-PROJECT-18K19584
[Presentation] 内因性TCRおよびMHC発現の抑制により非自己T細胞の利用を可能にしたT細胞輸注療法の開発2018
- Author(s)
  岡田怜美、安井潔、岡本幸子、峰野純一、竹迫一任、珠玖洋、江口晋、池田裕明
- Organizer
  第22回日本がん免疫学会総会
- Data Source
  KAKENHI-PROJECT-18K19584
[Presentation] 腫瘍の細胞性免疫応答反応性を規定するマクロファージの分化機構の解明2018
- Author(s)
  村岡大輔, 瀬尾尚宏, 林妙, 藤井啓介, 池田裕明, 秋吉一成, 原田直純, 珠玖洋
- Organizer
  第22回日本がん免疫学会総会
- Data Source
  KAKENHI-PROJECT-18K19584
[Presentation] 新規TCR遺伝子改変T細胞療法の臨床開発2018
- Author(s)
  池田裕明
- Organizer
  第2回 AMED/A*STAR 合同ワークショップ
- Invited / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-18H02872
[Presentation] Anti-tumor activity of CAR-T cells targeting the intracellular oncoprotein WT1 can be enhanced by vaccination2018
- Author(s)
  赤堀泰, 王立楠, 米山元裕, 瀬尾尚宏, 奥村悟司, 宮原慶裕, 天石泰典, 岡本幸子, 峯野純一, 池田裕明, 真木健裕, 藤原弘, 赤塚美樹, 加藤琢磨, 珠玖洋
- Organizer
  第22回日本がん免疫学会総会
- Data Source
  KAKENHI-PROJECT-18K19584
[Presentation] Development of TCR gene therapy with allogeneic “Stealth T cells” deficient in endogenous TCR and MHC class I molecules2018
- Author(s)
  Okada S, Muraoka D, Okamoto S, Mineno J, Shiku H, Eguchi S, Ikeda H
- Organizer
  第77回日本癌学会学術総会
- Data Source
  KAKENHI-PROJECT-18K19584
[Presentation] Anti-tumor activity of CAR-T cells targeting the intracellular oncoprotein WT1　can be enhanced by vaccination2018
- Author(s)
  赤堀　泰, 王　立楠, 米山　元裕, 瀬尾　尚宏, 奥村　悟司, 宮原　慶裕, 天石　泰典, 岡本　幸子, 峯野　純一, 池田　裕明, 真木　健裕, 藤原　弘, 赤塚　美樹, 加藤　琢磨, 珠玖　洋
- Organizer
  第22回日本がん免疫学会総会
- Data Source
  KAKENHI-PROJECT-18H02872
[Presentation] 造血器腫瘍に対する免疫細胞療法の開発2018
- Author(s)
  池田裕明
- Organizer
  第３９回久留米造血器腫瘍研究会
- Invited
- Data Source
  KAKENHI-PROJECT-18H02872
[Presentation] Development of TCR gene therapy with allogeneic “Stealth T cells” deficient in endogenous TCR and MHC class I molecules2018
- Author(s)
  Okada S, Muraoka D, Okamoto S, Mineno J, Shiku H, Eguchi S, Ikeda H
- Organizer
  第77回日本癌学会学術総会
- Data Source
  KAKENHI-PROJECT-18H02872
[Presentation] Cytokine release syndrome and tumor responses in a first-in-man trial of a novel affinity-enhanced TCR-gene transduced T cell transfer targeting NY-ESO-1 antigen2017
- Author(s)
  Hiroyoshi Hattori, Mikiya Ishihara, Shigehisa Kitano, Yoshihiro Miyahara, Hidefumi Kato, Hideyuki Mishima, Noboru Yamamoto, Hiroaki Iwase, Takeru Funakoshi, Takashi Kojima, Hiroaki Ikeda, Takashi Watanabe, , Shinichi Kageyama, Hiroshi Shiku
- Organizer
  2017 ESGCT
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-15H04918
[Presentation] NY-ESO-1 TCR遺伝子改変T細胞輸注におけるサイトカイン放出症候群発症と臨床反応2017
- Author(s)
  北野滋久、石原幹也、宮原慶裕、影山慎一、加藤栄史、三輪秀行、山本昇、岩瀬弘明、服部浩佳、船越建、小島隆嗣、池田裕明、渡辺隆、珠玖洋
- Organizer
  第２１回日本がん免疫学会学術総会
- Data Source
  KAKENHI-PROJECT-15H04918
[Presentation] NY-ESO-1を標的とするTCR遺伝子改変T細胞輸注療法における安全性の基礎的検討と輸注細胞動体及び血清学的解析2017
- Author(s)
  宮原慶裕、北野滋久、石原幹也、影山慎一、加藤栄史、三輪秀行、山本昇、岩瀬弘明、服部浩佳、船越建、小島隆嗣、池田裕明、渡辺隆、珠玖洋
- Organizer
  第２１回日本がん免疫学会学術総会
- Data Source
  KAKENHI-PROJECT-15H04918
[Presentation] Tumor-specific TCR-engineered Donor Lymphocytes Infusion for Tumor Relapse after Hematopoietic Stem Cell Transplantation in Mice.2017
- Author(s)
  Tawara Isao, Okamori Kana, Shiku Hiroshi, Ikeda Hiroaki, Katayama Naoyuki
- Organizer
  The 8th JSH Internationalsymposium
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-17K09949
[Presentation] がん免疫療法開発のガイダンス2016～がん免疫療法に用いる細胞製品の品質、非臨床試験の考え方～2017
- Author(s)
  池田裕明
- Organizer
  厚生労働省医薬品等審査迅速化事業費補助金　革新的医薬品・医療機器・再生医療製品実用化促進事業　公開シンポジウム　がん免疫療法2017　－複合化と個別化の科学基盤とレギュレーション－
- Place of Presentation
  東京大学　伊藤謝恩ホール（東京都・文京区)
- Invited
- Data Source
  KAKENHI-PROJECT-15H04918
[Presentation] がんのT細胞療法2017
- Author(s)
  池田裕明
- Organizer
  第５５回日本がん治療学会学術集会
- Invited
- Data Source
  KAKENHI-PROJECT-15H04918
[Presentation] Development of TCR-like scFv CAR that recognizes MAGE-A4230-239/HLA-A*02:012017
- Author(s)
  Yasushi Akahori, Yuya Kato, Yoshihiro Miyahara, Chisaki Amaike, Wang Linam, Takuma Kato, Hiroaki Ikeda, Hiroshi Shiku
- Organizer
  第76回　日本癌学会学術総会
- Data Source
  KAKENHI-PROJECT-15H04918
[Presentation] ネオアンチゲン等の新たながん免疫療法の標的2017
- Author(s)
  池田裕明
- Organizer
  厚生労働省医薬品等審査迅速化事業費補助金　革新的医薬品・医療機器・再生医療製品実用化促進事業　公開シンポジウム　がん免疫療法2017　－複合化と個別化の科学基盤とレギュレーション－
- Place of Presentation
  東京大学　伊藤謝恩ホール（東京都・文京区)
- Invited
- Data Source
  KAKENHI-PROJECT-15H04918
[Presentation] がん精巣抗原MAGE-A4由来ペプチドp230-239をHLA-A*02:01拘束性に認識するTCR様抗体を使用したCARによるがん抑制作用の検討2017
- Author(s)
  赤堀泰、加藤裕也、宮原慶裕、天池千咲、王立楠、加藤琢磨、池田裕明、珠玖洋
- Organizer
  第２１回日本がん免疫学会学術総会
- Data Source
  KAKENHI-PROJECT-15H04918
[Presentation] 10.Development of TCR gene therapy with allogeneic “Stealth T cells” deficient in ndogenous TCR and HLA class I molecules.2017
- Author(s)
  Okada S, Yasui K, Okamoto S, Mineno J, Tasesako K, Shiku H, Eguchi S, Ikeda H.
- Organizer
  第46回日本免疫学会学術集会
- Data Source
  KAKENHI-PROJECT-15H04918
[Presentation] Clinical trials of NY-ESO-1 and MAGE-A4 targeting TCR-gene transduced T cell transfer to patients with refractory solid tumors2017
- Author(s)
  Shinichi Kageyama, Mikiya Ishihara, Shigehisa Kitano, Yoshihiro Miyahara, Hidefumi Kato, Hideyuki Mishima, Noboru Yamamoto, Hiroaki Iwase, Hiroyoshi Hattori, Takeru Funakoshi, Takashi Kojima, Hiroaki Ikeda, Takashi Watanabe, Hiroshi Shiku
- Organizer
  第２３回　日本遺伝子細胞治療学会学術集会
- Invited
- Data Source
  KAKENHI-PROJECT-15H04918
[Presentation] 遺伝子改変細胞を用いた免疫療法の実用化に向けて2017
- Author(s)
  池田裕明
- Organizer
  第２１回日本がん免疫学会学術総会
- Invited
- Data Source
  KAKENHI-PROJECT-15H04918
[Presentation] Cytokine Release Syndrome and Tumor Responses in a First-in-Man Trial of a Novel Affinity-Enhanced TCR-Gene Transduced T Cell Transfer Targeting NY-ESO-1 Antigen2017
- Author(s)
  Kageyama S, Ishihara M, Kitano S, Miyahara Y, Kato H, Mishima H, Yamamoto N, Hattori H, Iwase H, Funakoshi T, Kojima T Inoue N, Kidokoro T, Tomura D, Okamoto S, Chono H, Nukaya I, Mineno J, Ikeda H, Watanabe T, Shiku H
- Organizer
  2017 米国血液学会総会
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-15H04918
[Presentation] 2.Extended applications of cancer immunotherapy with engineered T cells.2017
- Author(s)
  Hiroaki Ikeda
- Organizer
  The 36th Sapporo International Cancer Symposium
- Invited / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-15H04918
[Presentation] Tumor-specific Donor Lymphocyte Infusion for Tumor Relapse after Hematopoietic Cell Transplantation.2017
- Author(s)
  Tawara Isao, Okamori Kana, Shiku Hiroshi, Ikeda Hiroaki, Katayama Naoyuki
- Organizer
  第79回日本血液学会学術集会
- Data Source
  KAKENHI-PROJECT-17K09949
[Presentation] Tumor-Specific Donor Lymphocyte Infusion after Allogeneic Hematopoietic Stem Cell Transplantation2017
- Author(s)
  Tawara Isao, Katayama Naoyuki, Shiku Hiroshi, Ikeda Hiroaki
- Organizer
  第76回日本癌学会学術総会
- Data Source
  KAKENHI-PROJECT-17K09949
[Presentation] がん免疫療法の未来　～免疫チェクポイント阻害療法の先に～2017
- Author(s)
  池田裕明
- Organizer
  第２７回サイトメトリー学会
- Invited
- Data Source
  KAKENHI-PROJECT-15H04918
[Presentation] がんに対する遺伝子改変T細胞輸注療法の臨床開発2016
- Author(s)
  池田裕明
- Organizer
  第75回日本癌学会学術総会
- Place of Presentation
  パシフィコ横浜（神奈川県・横浜市）
- Invited
- Data Source
  KAKENHI-PROJECT-15H04918
[Presentation] Efficacy and safety of immunotherapy with chimeric antigen receptor targeting WT1 and HLA-A24:02 pMHC complex2016
- Author(s)
  Hiroaki Ikeda, Yasushi Akahori, Motohiro Yoneyama, Yuki Orito, Yoshihiro Miyahara, Yasunori Amaishi, Sachiko Okamoto, Junichi Mineno, Kazutoh Takesako, Hiroshi Fujiwara, Masaki Yasukawa, Hiroshi Shiku
- Organizer
  米国遺伝子細胞治療学会
- Place of Presentation
  Washigton DC, USA
- Year and Date
  2016-05-04
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-15H04918
[Presentation] がんに対するT細胞輸注療法の新展開2016
- Author(s)
  池田裕明
- Organizer
  第53回日本臨床分子医学会学術集会
- Place of Presentation
  東京国際フォーラム（東京都・千代田区）
- Invited
- Data Source
  KAKENHI-PROJECT-15H04918
[Presentation] Tumor-Specific Donor Lymphocyte Infusion for Tumor Relapse after MHC-Haploidentical Hematopoietic Stem Cell Transplantation2016
- Author(s)
  Isao Tawara, Kana Okamori, Naoyuki Katayama, Hiroshi Shiku, Hiroaki Ikeda.
- Organizer
  The 58th American Society of Hematology Annual Meeting & Exposition
- Place of Presentation
  San Diego, CA, USA
- Year and Date
  2016-12-03
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-15H04918
[Presentation] 癌の治癒を目指すＴ細胞輸注療法2016
- Author(s)
  池田裕明
- Organizer
  第２９回日本バイオセラピィ学会学術集会総会
- Place of Presentation
  久留米シティプラザ（福岡県・久留米市）
- Invited
- Data Source
  KAKENHI-PROJECT-15H04918
[Presentation] 同種移植後再発の成人T細胞白血病リンパ腫に対するT細胞レセプター遺伝子導入ドナーリンパ球輸注療法2016
- Author(s)
  池田裕明
- Organizer
  第3回日本HTLV-1学会
- Place of Presentation
  鹿児島県市町村自治会館（鹿児島県・鹿児島市）
- Invited
- Data Source
  KAKENHI-PROJECT-15H04918
[Presentation] Development of immunotherapy with chimeric antigen receptor targeting intracellular WT1 gene product presented on HLA-A*24:02 molecule2015
- Author(s)
  Yasushi Akahori, Motohiro Yoneyama, Hiroaki Ikeda, Yuki Orito, Yoshihiro Miyahara, Yasunori Amaishi, Sachiko Okamoto, Junichi Mineno, Kazutoh Takesako, Hiroshi Fujiwara,　Masaki Yasukawa,　Hiroshi Shiku
- Organizer
  がん免疫療法・マクロファージ国際会議 2015
- Place of Presentation
  東京大学（東京都・文京区）
- Year and Date
  2015-07-09
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-15H04918
[Presentation] Clinical development of TCR gene-therapy for patients with epithelial cancer and leukemia2015
- Author(s)
  Ikeda H
- Organizer
  第21回日本遺伝子治療学会学術集会
- Place of Presentation
  大阪国際会議場（大阪府・大阪市）
- Year and Date
  2015-07-24
- Invited
- Data Source
  KAKENHI-PROJECT-15H04918
[Presentation] Immunotherapy with chimeric antigen receptor targeting intracellular WT1 gene product complexed with HLA-A*24:02 molecule2015
- Author(s)
  Hiroaki Ikeda, Yasushi Akahori, Motohiro Yoneyama, Yuki Orito, Yoshihiro Miyahara, Yasunori Amaishi, Sachiko Okamoto, Junichi Mineno, Kazutoh Takesako, Hiroshi Fujiwara, Masaki Yasukawa, Hiroshi Shiku
- Organizer
  57th ASH Annual Meeting and Exposition
- Place of Presentation
  Orlando, USA
- Year and Date
  2015-12-05
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-15H04918
[Presentation] 遺伝子改変T細胞輸注による新たながん治療 New era of cancer immunotherapy with gene-engineered T cells2015
- Author(s)
  池田裕明
- Organizer
  第５３回日本癌治療学会学術集会
- Place of Presentation
  国立京都国際会館（京都市・左京区）
- Year and Date
  2015-10-29
- Invited
- Data Source
  KAKENHI-PROJECT-15H04918
[Presentation] Immunotherapy with antigen receptor engineered lymphocytes 「抗原受容体遺伝子導入リンパ球輸注療法」2015
- Author(s)
  Hiroaki Ikeda
- Organizer
  第１３回　日本臨床腫瘍学会学術集会
- Place of Presentation
  ロイトン札幌（札幌市・中央区）
- Year and Date
  2015-07-16
- Invited
- Data Source
  KAKENHI-PROJECT-15H04918
[Presentation] 癌治癒を目指すT細胞輸注療法の新展開 New era of adoptive T cell therapy forward the cure of cancer patients2015
- Author(s)
  池田裕明
- Organizer
  第７４回日本癌学会学術総会
- Place of Presentation
  名古屋国際会議場（愛知県・名古屋市）
- Year and Date
  2015-10-08
- Invited
- Data Source
  KAKENHI-PROJECT-15H04918
[Presentation] Donor lymphocyte infusion thrapy utilizing genetically engineered lymphocytes that express tumor-specific TCR and siRNA for endogenous TCR enables tumor eradication without GvHD induction.2015
- Author(s)
  Ikeda H, Ueno H, Tawara I, Kawamura A, Okamori K, Imai N, Okamoto S, Mineno J, Takesako K, Katayama N, Shiku H.
- Organizer
  13th Annual Meeting of Association of Cancer Immunotherapy (CIMT).
- Place of Presentation
  Mainz, Germany
- Year and Date
  2015-05-12
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-15H04918
[Presentation] T 細胞輸注療法~遺伝子改変 T 細胞療法を中心に~2015
- Author(s)
  池田裕明
- Organizer
  第148回日本医学会シンポジウム
- Place of Presentation
  日本医師会館（東京都・文京区）
- Year and Date
  2015-12-24
- Invited
- Data Source
  KAKENHI-PROJECT-15H04918
[Presentation] Development of TCR gene therapy with allogeneic T cells.2014
- Author(s)
  Hiroaki Uneno, Hiroaki Ikeda, Ayumi Kawamura, Makiko Yamane, Naoko Imai, Sachiko Okamoto, Junichi Mineno, Kazutoh Takesako, Hiroshi Shiku.
- Organizer
  第１８回日本がん免疫学会総会
- Place of Presentation
  ひめぎんホール、松山市
- Year and Date
  2014-07-04
- Data Source
  KAKENHI-PROJECT-24390300
[Presentation] TCR遺伝子改変T細胞輸注による新しいがん免疫療法の臨床開発2014
- Author(s)
  池田裕明
- Organizer
  第６３回日本輸血・細胞治療学会東海支部例会
- Place of Presentation
  名古屋第一赤十字病院、名古屋
- Year and Date
  2014-09-20
- Invited
- Data Source
  KAKENHI-PROJECT-24390300
[Presentation] Tumor-specific donor Lymphocyte infusion therapy with allogeneic T cells utilizing novel retrovirus vector silencing endogenous TCR expression.2014
- Author(s)
  Hiroaki Ikeda, Hiroaki Ueno, Ayumi Kawamura, Naoko Imai, Sachiko Okamoto, Junichi Mineno, Kazutoh Takesako, Hiroshi Shiku.
- Organizer
  Society for immunotherapy of Cancer 29th Annual Meeting
- Place of Presentation
  National Harbor, USA
- Year and Date
  2014-11-07
- Data Source
  KAKENHI-PROJECT-24390300
[Presentation] TCR gene therapy with allogeneic T cells2014
- Author(s)
  Hiroaki Ikeda, Hiroaki Uneno, Ayumi Kawamura, Makiko Yamane, Naoko Imai, Sachiko Okamoto, Junichi Mineno, Kazutoh Takesako, Hiroshi Shiku.
- Organizer
  第２０回日本遺伝子治療学会学術集会
- Place of Presentation
  東京慈恵会医科大学、東京
- Year and Date
  2014-08-08
- Data Source
  KAKENHI-PROJECT-24390300
[Presentation] Tumor-specific TCR-engineered donor lymphocyte infusion therapy with reduced GVHD induction utilizing novel retrovirus vector silencing endogenous TCR expression.2014
- Author(s)
  Hiroaki Ikeda, Hiroaki Ueno, Isao Tawara, Ayumi Kawamura, Naoko Imai, Sachiko Okamoto, Junichi Mineno, Kazutoh Takesako, Naoyuki Katayama, Hiroshi Shiku.
- Organizer
  American Society of Hematology 56th annual meeting
- Place of Presentation
  San Francisco, USA
- Year and Date
  2014-12-08
- Data Source
  KAKENHI-PROJECT-24390300
[Presentation] Development of chimeric antigen receptor immunotherapy targeting intracellular WT1 gene product.2014
- Author(s)
  Yasushi Akahori, Motohiro Yoneyama, Hiroaki Ikeda, Yuki Orito, Yoshihiro Miyahara, Yasunori Amaishi, Sachiko Okamoto, Junichi Mineno, Kazutoh Takesako, Hiroshi Shiku.
- Organizer
  第２０回日本遺伝子治療学会学術集会
- Place of Presentation
  東京慈恵会医科大学、東京
- Year and Date
  2014-08-08
- Data Source
  KAKENHI-PROJECT-24390300
[Presentation] WT1ペプチド-HLA-A24複合体を認識するヒト抗体の単離とそれを用いたCAR治療法の開発2014
- Author(s)
  赤堀泰　米山元裕　池田裕明　宮原慶裕　織戸由貴　天石泰典　岡本幸子　峰野純一　竹迫一任　珠玖洋
- Organizer
  第１８回日本がん免疫学会総会
- Place of Presentation
  ひめぎんホール、松山市
- Year and Date
  2014-07-04
- Data Source
  KAKENHI-PROJECT-24390300
[Presentation] Acquisition of multifunctionality impacts CD8+ T cell survival and memory formation2013
- Author(s)
  Naoko Imai, Makiko Yamane, Kazuko Shirakura, Linan Wang, Hiroaki Ikeda, Hiroshi Shiku
- Organizer
  第７２回　日本癌学会学術総会
- Place of Presentation
  横浜市
- Data Source
  KAKENHI-PROJECT-24390300
[Presentation] Enhancement of the Tumoricidal Effects by Oncolytic virus HF10 in Combination with GITR-specific DTA-1 mAb2013
- Author(s)
  Mikiya Ishihara, Naohiro Seo, Daisuke Muraoka, Maki Tanaka, Junichi Mineno, Hiroaki Ikeda, Hiroshi Shiku
- Organizer
  第７２回　日本癌学会学術総会
- Place of Presentation
  横浜市
- Data Source
  KAKENHI-PROJECT-24390300
[Presentation] ANTIGEN RECEPTOR GENE-MODIFIED LYMPHOCYTES : HARNESSING T CELLS FOR EFFECTIVE CANCER TREATMENT WITH NOVEL VECTORS AND MANIPULATIONS2013
- Author(s)
  Ikeda H, Kageyama S, Imai N, Miyahara Y, Ishihara M, Kawamura A, Yamane M, Tomura D, Okamoto S, Nukaya I, Mineno J, Takesako K Katayama N, Shiku H.
- Organizer
  Ninth AACR-Japanese Cancer Association Joint Conference
- Place of Presentation
  Maui, HI, USA
- Year and Date
  2013-02-24
- Data Source
  KAKENHI-PROJECT-24390300
[Presentation] TCR gene therapy with allogeneic T cells2013
- Author(s)
  Hiroaki Ikeda, Ayumi Kawamura, Naoko Imai, Sachiko Okamoto, Junichi Mineno, Kazutoh Takesako, Hiroshi Shiku
- Organizer
  第４２回　日本免疫学会学術集会
- Place of Presentation
  千葉市
- Data Source
  KAKENHI-PROJECT-24390300
[Presentation] T細胞輸注療法　―遺伝子改変T細胞の利用―2013
- Author(s)
  池田裕明
- Organizer
  第17回日本がん分子標的治療学会学術集会
- Place of Presentation
  京都
- Data Source
  KAKENHI-PROJECT-24390300
[Presentation] 遺伝子改変T細胞輸注療法のトランスレーショナルリサーチ2013
- Author(s)
  池田裕明
- Organizer
  第４１回　日本臨床免疫学会総会
- Place of Presentation
  下関市
- Invited
- Data Source
  KAKENHI-PROJECT-24390300
[Presentation] TCR gene therapy with allogeneic T cells2013
- Author(s)
  Hiroaki Ikeda, Ayumi Kawamura, Naoko Imai, Makiko Yamane, Sachiko Okamoto, Junichi Mineno, Kazutoh Takesako, Hiroshi Shiku
- Organizer
  The 4th JSH international symposium
- Place of Presentation
  松山市
- Data Source
  KAKENHI-PROJECT-24390300
[Presentation] In vivo persistence of adoptively transferred TCR gene-transduced lymphocytes with anti-tumor reactivity in patients with MAGE-A4 expressing esophageal cancer2013
- Author(s)
  Hiroaki Ikeda, Shinichi Kageyama, Naoko Imai, Yoshihiro Miyahara, Mikiya Ishihara, Naoyuki Katayama, Hirofumi Yoshioka, Daisuke Tomura, Ikuei Nukaya, Junichi Mineno, Kazuto Takesako, Hiroshi Shiku
- Organizer
  28th Annual Meeting of Society for Immunotherapy of Cancer
- Place of Presentation
  National Harbor, MD, USA
- Data Source
  KAKENHI-PROJECT-24390300
[Presentation] Adoptive cell therapy with antigen receptor engineered T cells2013
- Author(s)
  Hiroaki Ikeda
- Organizer
  第７２回　日本癌学会学術総会
- Place of Presentation
  横浜市
- Invited
- Data Source
  KAKENHI-PROJECT-24390300
[Presentation] Adoptively transferred TCR gene-transduced lymphocytes persist with anti-tumor reactivity in patients with MAGE-A4+ esophageal cancer2013
- Author(s)
  Hiroaki Ikeda, Shinichi Kageyama, Naoko Imai, Yoshihiro Miyahara, Mikiya Ishihara, Yasuhiro Nagata, Naoyuki Katayama, Hirofumi Yoshioka, Daisuke Tomura, Ikuei Nukaya, Junichi Mineno, Kazuto Takesako, Hiroshi Shiku
- Organizer
  ESGCT and SETGyC Collaborative Congress, Madrid
- Place of Presentation
  Madrid, Spain
- Data Source
  KAKENHI-PROJECT-24390300
[Presentation] 抗原受容体遺伝子改変T細胞輸注療法2013
- Author(s)
  池田裕明
- Organizer
  第１７回日本がん免疫学会総会
- Place of Presentation
  宇部市
- Invited
- Data Source
  KAKENHI-PROJECT-24390300
[Presentation] 食道癌を対象にしたMAGE-A4特異的TCR遺伝子導入リンパ球輸注における輸注細胞の体内動態と臨床評価2013
- Author(s)
  影山　慎一、池田　裕明、今井　奈緒子、石原　幹也、斎藤　佳菜子、上田　修吾、石川　剛、古倉　聡、直田　浩明、宮原　慶裕、城所　知秀、井上　直樹、田辺　雅茂、吉岡　広文、戸村　大助、糠谷　育衛、岡本　幸子、峰野　純一、白石　泰三、大石　晃嗣、片山　直之、珠玖　洋
- Organizer
  第１７回日本がん免疫学会総会
- Place of Presentation
  宇部市
- Data Source
  KAKENHI-PROJECT-24390300
[Presentation] マウス皮下移植腫瘍モデルを用いた腫瘍溶解性HSV-1自然変異株HF10療法におけるGITR特異的抗体併用での抗腫瘍効果の検討2013
- Author(s)
  石原　幹也、瀬尾　尚宏、村岡　大輔、田中　舞紀、峰野　純一、池田　裕明、珠玖　洋
- Organizer
  第１７回日本がん免疫学会総会
- Place of Presentation
  宇部市
- Data Source
  KAKENHI-PROJECT-24390300
[Presentation] 機能制御性キメラ抗原レセプター（CAR）導入T細胞輸注療法の開発2013
- Author(s)
  加藤琢磨、王立楠、池田裕明、日向千咲、岡本幸子、天石泰典、峰野純一、竹迫一任、珠玖洋
- Organizer
  第７２回　日本癌学会学術総会
- Place of Presentation
  横浜市
- Data Source
  KAKENHI-PROJECT-24390300
[Presentation] Evaluation of "siTCR" vectors using novel mouse model of T cell receptor gene therapy.2012
- Author(s)
  Imai N, Kawamura A Yamane M, Wang L, Shirakura K, Shirakura K, Amaike C, Goto Y, Okamoto S, Mineno J, Takesako K Ikeda H, Shiku H.
- Organizer
  第18回日本遺伝子治療学会学術集会
- Place of Presentation
  熊本
- Year and Date
  2012-06-29
- Data Source
  KAKENHI-PROJECT-24390300
[Presentation] Evaluation of vector construction of TCR gene therapy for cancer utilizing a novel mouse model.2012
- Author(s)
  Imai N, Kawamura A, Yamane M, Wang L, Shirakura K, Shi rakura K, Amaike C, Goto Y, Okamoto S, Mineno J, Takesako K Ikeda H, Shiku H.
- Organizer
  第41回日本免疫学会学術集会
- Place of Presentation
  神戸
- Year and Date
  2012-12-06
- Data Source
  KAKENHI-PROJECT-24390300
[Presentation] 遺伝子改変T細胞の臨床応用2012
- Author(s)
  池田裕明、影山慎一、宮原慶裕、今井奈緒子、石原幹也、岡本幸子、糠谷育衛、峰野純一、竹迫一任、珠玖洋
- Organizer
  第16回日本がん免疫学会総会
- Place of Presentation
  札幌(招待講演)
- Year and Date
  2012-07-28
- Data Source
  KAKENHI-PROJECT-24390300
[Presentation] T細胞レセプター遺伝子導入リンパ球輸注療法のマウスモデルによる解析2012
- Author(s)
  今井奈緒子、河村あゆみ、山根真妃子、王立楠、後藤優美、岡本幸子、峰野純一、竹迫一任、池田裕明、珠玖洋
- Organizer
  第16回日本がん免疫学会総会
- Place of Presentation
  札幌
- Year and Date
  2012-07-26
- Data Source
  KAKENHI-PROJECT-24390300
[Presentation] CHP-MAGE-A4がんワクチン療法におけるIgGサブクラスおよびIgE抗体反応の重要性についての検討2012
- Author(s)
  京極典憲、土川貴裕、宮本正樹、安孫子剛大、黒田晶、真木健裕、山村喜之、田中公貴、市之川正臣、平野聡、池田_裕明、影山愼一、珠玖洋、近藤哲
- Organizer
  第112回日本外科学会定期学術集会
- Place of Presentation
  幕張
- Year and Date
  2012-04-12
- Data Source
  KAKENHI-PROJECT-24390300
[Presentation] T Cell Receptor Gene-Modified Lymphocytes : A Translat ional Bridge to Effective Cancer Immunotherapy.2012
- Author(s)
  Ikeda H.
- Organizer
  日本癌学会・日本がん免疫学会主催 Lloyd J 01d Memorial Symposium 「がん免疫研究の新しい挑戦 - 01d先生の軌跡を継承しつつ-」
- Place of Presentation
  札幌(招待講演)
- Year and Date
  2012-09-22
- Data Source
  KAKENHI-PROJECT-24390300
[Presentation] がんワクチンがTh1/Th2 Tregのバランスに与える影響2012
- Author(s)
  安孫子剛大、土川貴裕、宮本正樹、京極典憲、池田裕明、影山愼一、珠玖洋、平野聡
- Organizer
  第71回日本癌学会学術総会
- Place of Presentation
  札幌
- Year and Date
  2012-09-19
- Data Source
  KAKENHI-PROJECT-24390300
[Presentation] Clinical application of gene-modified lymphocytes for cancer immunotherapy.2012
- Author(s)
  Ikeda H, Kageyama S, Imai N, Miyahara Y, Ishihara M, Kawamura A, Yamane M, Tomura D, Okamoto S, Nukaya I, Mineno J, Takesako K, Katayama N, Shiku H.
- Organizer
  第18回日本遺伝子治療学会学術集会
- Place of Presentation
  熊本(招待講演)
- Year and Date
  2012-06-29
- Data Source
  KAKENHI-PROJECT-24390300
[Presentation] The importance of IgG subclass and IgE response in CHP-MAGE-A4 cancer vaccination2011
- Author(s)
  Noriaki Kyogoku, Takahiro Tsuchikawa, Masaki Miyamoto, Takeiro Abiko, Aki Kuroda, Takehiro Maki, Yoshiyuki Yamamura, Satoshi Hirano, Satoshi Kondo, Hiroaki Ikeda, Shinichi Kageyama, Hiroshi Shiku
- Organizer
  第70回日本癌学会学術総会
- Place of Presentation
  名古屋
- Year and Date
  2011-10-05
- Data Source
  KAKENHI-PROJECT-21591664
[Presentation] Highly efficient and safe vectors for TCR gene therapy : Silencing of endogenous TCR improved expression and anti-tumor reactivity of transduced tumor-specific TCRs in human lymphocytes2011
- Author(s)
  Sachiko Okamoto, Hiroaki Ikeda, Hiroshi Fujiwara, Ikuei Nukaya, Hirofumi Yoshioka, Masaki Yasukawa, Hiroshi Shiku, Junichi Mineno
- Organizer
  14th Annual meeting of American Society of Gene & Cell Therapy
- Place of Presentation
  Seattle WA USA
- Data Source
  KAKENHI-PROJECT-21591664
[Presentation] Signals through VLA-4 and -5 in CD8^+ T cell improve the efficacy of adoptive therapy of tumor2011
- Author(s)
  Hayato Hosoi, Hiroaki Ikeda, Chisaki Hyuga, Linan Wang, Yuki Orito, Ikuei Nukaya, Tatsuji Enoki, Junichi Mineno, Kazuto Takesako, Satoshi Kondo' Hiroshi Shiku
- Organizer
  第70回日本癌学会学術総会
- Place of Presentation
  名古屋
- Year and Date
  2011-10-04
- Data Source
  KAKENHI-PROJECT-21591664
[Presentation] 内在性TCRのノックダウンによる高効率かつ安全性の高いTCR遺伝子治療法の開発2011
- Author(s)
  岡本幸子、池田裕明、藤原弘、糠谷育英、吉岡広文、葛島清隆、安川正貴、珠玖洋、峰野純一
- Organizer
  第15回日本がん免疫学会総会
- Place of Presentation
  大阪
- Data Source
  KAKENHI-PROJECT-21591664
[Presentation] Gene-modified T cell therapy : Harnessing lymphocytes for effective cancer treatment2011
- Author(s)
  Hiroaki Ikeda, Naoko Imai, Hayato Hosoi, Makiko Yamane, Sachiko Okamoto, Junichi Mineno, Kazutoh Takesako, Shinichi Kageyama, Hiroshi Shiku
- Organizer
  第70回日本癌学会学術総会招待講演
- Place of Presentation
  名古屋
- Year and Date
  2011-10-03
- Data Source
  KAKENHI-PROJECT-21591664
[Presentation] Gene-modified T cell therapy : Harnessing lymphocytes for effective cancer treatment2011
- Author(s)
  Hiroaki Ikeda, Naoko Ima1, Hayato Hosoi, Makiko Yamane, Sachiko Okamoto, Junichi Mineno, Kazutoh Takesako, Shinichi Kageyama, Hiroshi Shiku
- Organizer
  第70回日本癌学会学術総会
- Place of Presentation
  名古屋(招待講演)
- Year and Date
  2011-10-03
- Data Source
  KAKENHI-PROJECT-21591664
[Presentation] siRNA-mediated silencing of PD-1 ligands of tumor-specific human T cells enhances T cell function2011
- Author(s)
  Koichi Iwamura, Takuma Katoh, Yoshihiro Miyahara, Hiroaki Naota, Junichi Mineno, Hiroaki Ikeda, Kazutoh Takesako, Hiroshi Shiku
- Organizer
  第70回日本癌学会学術総会
- Place of Presentation
  名古屋
- Year and Date
  2011-10-05
- Data Source
  KAKENHI-PROJECT-21591664
[Presentation] In vivo persistence of adoptively transferred TCR gene-modified lymp hocytes in patients with advanced esophageal cancer2011
- Author(s)
  Shinichi Kageyama, Hiroaki Ikeda, Yoshihiro Miyahara, Sahoko Hori, Kanako Saito, Naoko Imai, Sachiko Okamoto, Daisuke Tomura, Ikuei Nukaya, Junichi Mineno, Kazutoh Takesako, Naoyuki Katayama, Hiroshi Shiku
- Organizer
  第70回日本癌学会学術総会
- Place of Presentation
  名古屋
- Year and Date
  2011-10-04
- Data Source
  KAKENHI-PROJECT-21591664
[Presentation] 遺伝子改変T細胞輸注療法2011
- Author(s)
  池田裕明、今井奈緒子、細井勇人、山根真妃子、岡本幸子、峰野純一、竹迫一任、影山慎一、珠玖洋
- Organizer
  第15回日本がん免疫学会総会招待講演
- Place of Presentation
  大阪
- Data Source
  KAKENHI-PROJECT-21591664
[Presentation] VLA-4、VLA-5シグナルはCTL輸注療法の抗腫瘍効果を向上する2011
- Author(s)
  細井勇人、池田裕明、日向千咲、王立楠、織戸由貴、糠谷育衛、榎竜嗣、峰野純一、竹迫一任、近藤哲、珠玖洋
- Organizer
  第15回日本がん免疫学会総会
- Place of Presentation
  大阪
- Data Source
  KAKENHI-PROJECT-21591664
[Presentation] Silencing of endogenous TCR improved the efficacy and safety in TCR gene therapy2011
- Author(s)
  Sachiko Okamoto, Hiroaki Ikeda, Hiroshi Fujiwara, Ikuei Nukaya, Hirofumi Yoshioka, Kiyotaka Kuzushima, Masaki Yasukawa, Hiroshi Shiku, Junichi Mineno
- Organizer
  第70回日本癌学会学術総会
- Place of Presentation
  名古屋
- Year and Date
  2011-10-04
- Data Source
  KAKENHI-PROJECT-21591664
[Presentation] ANTIGEN RECEPTOR GENE-MODIFIED LYMPHOCYTES : HARNESSING T CELLS FOR EFFECTIVE CANCER TREATMENT2011
- Author(s)
  Hiroaki Ikeda, Naoko Imai, Hayato Hosoi, Makiko Yamane, Sachiko Okamoto, Junichi Mineno, Shinichi Kageyama, Kazutoh Takesako, Hiroshi Shiku
- Organizer
  第17回日本遺伝子治療学会2011年次学術集会招待講演
- Place of Presentation
  福岡
- Data Source
  KAKENHI-PROJECT-21591664
[Presentation] Multifunctionality determines T cell survival fate2011
- Author(s)
  Naoko Imai, Hiroaki Ikeda, Isao Tawara, Hayato Hosoi, Kazuko Mori, Chisato Hyuga, Makiko Yamane, Linan Wang, Hiroshi Shiku
- Organizer
  第70回日本癌学会学術総会
- Place of Presentation
  名古屋
- Year and Date
  2011-10-05
- Data Source
  KAKENHI-PROJECT-21591664
[Presentation] ANTIGEN RECEPTOR GENE-MODIFIED LYMPHOCYTES : HARNESSING T CELLS FOR EFFECTIVE CANCER TREATMENT2011
- Author(s)
  Hiroaki Ikeda, Naoko Imai, Hayato Hosoi, Makiko Yamane, Sachiko Okamoto, Junichi Mineno, Shinichi Kageyama, Kazutoh Takesako, Hiroshi Shiku
- Organizer
  第17回日本遺伝子治療学会
- Place of Presentation
  福岡(招待講演)
- Data Source
  KAKENHI-PROJECT-21591664
[Presentation] T細胞のマルチファンクション性はその生存性と輸注療法の効果を規定する2011
- Author(s)
  今井奈緒子、池田裕明、細井勇人、俵功、山根真妃子、王立楠、森和子、日向千咲、珠玖洋
- Organizer
  第40回日本免疫学会学術集会
- Place of Presentation
  千葉
- Year and Date
  2011-11-28
- Data Source
  KAKENHI-PROJECT-21591664
[Presentation] 遺伝子改変T細胞輸注療法2011
- Author(s)
  池田裕明、今井奈緒子、細井勇人、山根真妃子、岡本幸子、峰野純一、竹迫一任、影山慎一、珠玖洋
- Organizer
  第15回日本がん免疫学会総会
- Place of Presentation
  大阪(招待講演)
- Data Source
  KAKENHI-PROJECT-21591664
[Presentation] Nucleic MAGE-A4 promotes apoptosis in p53-overexpressing cancer cells of non-small cell lung carcinoma2011
- Author(s)
  Aki Kuroda, Masaki Miyamoto, Takehiro Abiko, Takahiro Tsuchikawa, Noriaki Kyogoku, Takehiro Maki, Yoshiyuki Yamamura, Yasuhiro Hida, Kichizo Kaga, Satoshi Hirano, Hiroaki Ikeda, Hiroshi Shiku, Satoshi Kondo
- Organizer
  第70回日本癌学会学術総会
- Place of Presentation
  名古屋
- Year and Date
  2011-10-04
- Data Source
  KAKENHI-PROJECT-21591664
[Presentation] インテグリンシグナルを介した教育による効果的なT細胞療法の確立2011
- Author(s)
  細井勇人、池田裕明、日向千咲、王立楠、織戸由貴、今井奈緒子、糠谷育衛、榎竜嗣、峰野純一、竹迫一任、近藤哲、珠玖洋
- Organizer
  第40回日本免疫学会学術集会
- Place of Presentation
  千葉
- Year and Date
  2011-11-28
- Data Source
  KAKENHI-PROJECT-21591664
[Presentation] ヒト腫瘍抗原特異的T細胞へのPD-L1/PD-L2 siRNA導入によるT細胞機能の増強2011
- Author(s)
  岩村康一、加藤琢磨、宮原慶裕、直田浩明、峰野純一郎、岡本幸子、池田裕明、竹迫一任、珠玖洋
- Organizer
  第15回日本がん免疫学会総会
- Place of Presentation
  大阪
- Data Source
  KAKENHI-PROJECT-21591664
[Presentation] CD8^+細胞傷害性T細胞の制御によるがん免疫療法2010
- Author(s)
  池田裕明、今井奈緒子、岡本幸子、峰野純一、影山慎一、珠玖洋
- Organizer
  第20回日本サイトメトリー学会学術集会
- Place of Presentation
  東京
- Data Source
  KAKENHI-PROJECT-21591664
[Presentation] A novel STAT3 inhibitor reverses tumor-associated immunosuppression and enhances the efficacy of adoptive T cell therapy of cancer2010
- Author(s)
  Ikeda H, Sugiyama D, Muraoka D, Imai N, Harada N, Akiyama Y, Asai A, Shiku H
- Organizer
  International Society of Biological Therapy of Cancer, Annual Meeting 2010
- Place of Presentation
  Washington D. C., USA
- Data Source
  KAKENHI-PROJECT-21591664
[Presentation] がん特異的T細胞輸注療法の新展開2010
- Author(s)
  池田裕明、今井奈緒子、王立楠、細井勇人、岡本幸子、峰野純一、影山慎一、珠玖洋
- Organizer
  第31回日本臨床薬理学会年会招待講演
- Place of Presentation
  京都
- Data Source
  KAKENHI-PROJECT-21591664
[Presentation] Gene-Modified Lymphocytes : Harnessing T Cells for Effective Cancer Treatment2010
- Author(s)
  Ikeda H, Okamoto S, Mineno J, Imai N, Kageyama S, Ito M, Yasukawa M, Takesako K, Shiku H
- Organizer
  International Society for Cell Therapy, 1^<st> Asia-Pacific Regional Meeting
- Place of Presentation
  宮崎(招待講演)
- Year and Date
  2010-10-20
- Data Source
  KAKENHI-PROJECT-21591664
[Presentation] Shiku H CD4^+ T cell help on the induction of functional tumor-specific CD8^+ T cells with survival marker2010
- Author(s)
  Imai N, Ikeda H, Tawara I, Mori K, Yamane M, Wang L
- Organizer
  14th International Congress of Immunology
- Place of Presentation
  Kobe, Japan
- Year and Date
  2010-08-23
- Data Source
  KAKENHI-PROJECT-21591664
[Presentation] CD8^+細胞傷害性T細胞の制御によるがん免疫療法2010
- Author(s)
  池田裕明、今井奈緒子、岡本幸子、峰野純一、影山慎一、珠玖洋
- Organizer
  第20回日本サイトメトリー学会学術集会
- Place of Presentation
  東京(招待講演)
- Year and Date
  2010-06-27
- Data Source
  KAKENHI-PROJECT-21591664
[Presentation] CD4^+ T cell help on the induction of functional tumor-specific CD8^+ T cells with survival marker2010
- Author(s)
  Imai N, Ikeda H, Tawara I, Mori K, Yamane M, Wang L, Shiku H
- Organizer
  14th International Congress of Immunology
- Place of Presentation
  神戸
- Year and Date
  2010-08-13
- Data Source
  KAKENHI-PROJECT-21591664
[Presentation] The clinical response of novel CHP-MAGE-A4 cancer vaccine for the patients of gastro-intestinal malignancies refractory to the standard treatment. -the result of phase I clinical study2010
- Author(s)
  Tsuchikawa T, Kyogoku N, Miyamoto M, Abiko T, Murota C, Kuroda A, Maki T, Yamamura Y, Hirano S, Kondo S, Ikeda H, Kageyama S, Shiku H
- Organizer
  CRI symposium
- Place of Presentation
  米国、ニューヨーク
- Data Source
  KAKENHI-PROJECT-21591664
[Presentation] GENE-MODIFIED LYMPHOCYTES : A TRANSLATIONAL BRIDGE TO EFFECTIVE T CELL THERAPY OF CANCER2010
- Author(s)
  Ikeda H, Okamoto S, Mineno J, Imai N, Kageyama S, Ito M, Yasukawa M, Takesako K, Shiku H
- Organizer
  第16回日本遺伝子治療学会総会
- Place of Presentation
  宇都宮
- Data Source
  KAKENHI-PROJECT-21591664
[Presentation] The next generation TCR gene therapy for cancer2010
- Author(s)
  Okamoto S, Ikeda H, Fujiwara H, Yasukawa M, Shiku H, Mineno J
- Organizer
  第69回日本癌学会
- Place of Presentation
  大阪
- Data Source
  KAKENHI-PROJECT-21591664
[Presentation] THE NEXT GENERATION TCR GENE THERAPY : SILENCING OF ENDOGENOUS TCR IMPROVES THE EFFICACY OF TCR GENE THERAPY2010
- Author(s)
  Okamoto S, Ikeda H, Fujiwara H, Yasukawa M, Shiku H, Mineno J
- Organizer
  第16回日本遺伝子治療学会
- Place of Presentation
  宇都宮
- Data Source
  KAKENHI-PROJECT-21591664
[Presentation] CD4^+T細胞が腫瘍特異的CD8^+T細胞のマルチファンクション性・生存性・抗腫瘍活性に与える影響2010
- Author(s)
  今井奈緒子、池田裕明、山根真妃子、王立楠、珠玖洋
- Organizer
  第14回日本がん免疫学会学術集会
- Place of Presentation
  熊本
- Year and Date
  2010-07-22
- Data Source
  KAKENHI-PROJECT-21591664
[Presentation] がん特異的T細胞輸注療法の新展開2010
- Author(s)
  池田裕明、今井奈緒子、王立楠、細井勇人、岡本幸子、峰野純一、影山慎一、珠玖洋
- Organizer
  第31回日本臨床薬理学会年会
- Place of Presentation
  京都(招待講演)
- Year and Date
  2010-12-03
- Data Source
  KAKENHI-PROJECT-21591664
[Presentation] A novel STAT3 inhibitor reverses tumor-associated immunosuppression and enhances the efficacy of adoptive T cell therapy of cancer2010
- Author(s)
  Ikeda H, Sugiyama D, Muraoka D, Imai N, Harada N, Akiyama Y Asai A, Shiku H
- Organizer
  CRI symposium
- Place of Presentation
  米国、ニューヨーク
- Data Source
  KAKENHI-PROJECT-21591664
[Presentation] Interaction with fibronectin fragment (RetroNectin) on TCR stimulation enhances proliferation and survival of human peripheral T cells2010
- Author(s)
  Hosoi H, Ikeda H, Hyuga C, Orito Y, Nukaya I, Enoki R, Mineno J, Takesako K, Kondo S, Shiku H
- Organizer
  CRI symposium
- Place of Presentation
  米国、ニューヨーク
- Data Source
  KAKENHI-PROJECT-21591664
[Presentation] CD4^+T細胞が腫瘍特異的CD8^+T細胞のマルチファンクション性・生存性・抗腫瘍活性に与える影響2010
- Author(s)
  Imai N, Ikeda H, Hosoi H, Yamane M, Wang L, Shiku H
- Organizer
  第69回日本癌学会
- Place of Presentation
  大阪
- Data Source
  KAKENHI-PROJECT-21591664
[Presentation] GENE-MODIFIED LYMPHOCYTES : A TRANSLATIONAL BRIDGE TO EFFECTIVE T CELL THERAPY OF CANCER2010
- Author(s)
  Ikeda H, Okamoto S, Mineno J, Imai N, Kageyama S, Ito M, Yasukawa M, Takesako K, Shiku H
- Organizer
  第16回日本遺伝子治療学会総会
- Place of Presentation
  宇都宮(招待講演)
- Year and Date
  2010-07-03
- Data Source
  KAKENHI-PROJECT-21591664
[Presentation] Interaction with fibronectin fragment(RetroNectin) on TCR stimulation enhances proliferation and survival of human peripheral T cells2010
- Author(s)
  Hosoi H, Ikeda H, Hyuga C, Orito Y, Nukaya I, Enoki R, Mineno J, Takesako K, Kondo S, Shiku H
- Organizer
  CRI symposium 2010
- Place of Presentation
  NY, USA
- Data Source
  KAKENHI-PROJECT-21591664
[Presentation] Intra-tumor secretion of GITRL-Fc fusion protein induces and activates tumor-specific CD8^+ T cells resulting in tumor regression2010
- Author(s)
  Ikeda H, Mitsui J, Ishihara M, Hosoi H, Mineno J, Kondo S, Shiku H
- Organizer
  第16回日本遺伝子治療学会
- Place of Presentation
  宇都宮
- Data Source
  KAKENHI-PROJECT-21591664
[Presentation] Gene-Modified Lymphocytes : Harnessing T Cells for Effective Cancer Treatment. International Society for Cell Therapy2010
- Author(s)
  Ikeda H, Okamoto S, Mineno J, Imai N, Kageyama S, Ito M, Yasukawa M, Takesako K, Shiku H
- Organizer
  1^<st> Asia-Pacific Regional Meeting,招待講演
- Place of Presentation
  Miyazaki, Japan
- Data Source
  KAKENHI-PROJECT-21591664
[Presentation] A critical role for the multifunctionality of anti-tumor human T cells in TCR gene therapy evaluated in an in vivo model utilizing NOG mice2009
- Author(s)
  水野優香理, 池田裕明, 白倉由隆, 日浅厚則, 日向千咲, 王立楠, 今井奈緒子, 佐藤永一, 伊藤守, 柳承信, 峰野純一, 加藤郁之進, 珠玖洋
- Organizer
  CRI symposium
- Place of Presentation
  米国、ニューヨーク
- Data Source
  KAKENHI-PROJECT-21591664
[Presentation] CD^<4+> T cells play a critical role in the induction of multifunctionality of tumor-specific CD8^+ T cells resulting in effective tumor eradication2009
- Author(s)
  Imai N, Ikeda H, Tawara I, Mori K, Yamane M, Wang L, Shiku H
- Organizer
  CRI symposium 2009
- Place of Presentation
  NY, USA
- Data Source
  KAKENHI-PROJECT-21591664
[Presentation] Silencing endogenous tcr α/β with sirnas and protecting transferred MAGE-A4-specific tcr α/β genes from siRNAs by codon modification enhance expression of transferred TCR α/β2009
- Author(s)
  Mineno J, Okamoto S, Ikeda H, Shiku H, Kato I
- Organizer
  第15回日本遺伝子治療学会総会
- Place of Presentation
  大阪
- Data Source
  KAKENHI-PROJECT-21591664
[Presentation] Specific silencing of endogenous TCR with siRNAs in human lymphocytes improved expression and anti-tumor reactivity of transduced tumor-specific TCRs2009
- Author(s)
  Okamoto S, Mineno J, Ikeda H, Fujiwara H, Yasukawa M, Shiku H, Kato I
- Organizer
  24^<th> Annual Meeting of iSBTc
- Place of Presentation
  Washington, D. C., USA
- Data Source
  KAKENHI-PROJECT-21591664
[Presentation] Improved expression and anti-tumor reactivity of transduced tumor-specific TCRs in human lymphocytes by specific silencing of endogenous TCR2009
- Author(s)
  Okamoto S, Mineno J, Ikeda H, Fujiwara H, Yasukawa M, Shiku H, Kato I
- Organizer
  CRI symposium
- Place of Presentation
  米国、ニューヨーク
- Data Source
  KAKENHI-PROJECT-21591664
[Presentation] MAGE-A4特異的TCR遺伝子導入T細胞移入療法モデルにおけるヒトT細胞のマルチファンクション性誘導の検討2009
- Author(s)
  水野優香理, 池田裕明, 白倉由隆, 日浅厚則, 日向千咲, 王立楠, 今井奈緒子, 佐藤永一, 伊藤守, 柳承信, 峰野純一, 加藤郁之進, 珠玖洋
- Organizer
  第13回日本がん免疫学会総会
- Place of Presentation
  小倉
- Data Source
  KAKENHI-PROJECT-21591664
[Presentation] CD4^+ T cells play a critical role in the induction of multifunctionality of tumor-specific CD8^+ T cells resulting in effective tumor eradication2009
- Author(s)
  Imai N, Ikeda H, Tawara I, Mori K, Yamane M, Wang L, Shiku H
- Organizer
  CRI symposium
- Place of Presentation
  米国、ニューヨーク
- Data Source
  KAKENHI-PROJECT-21591664
[Presentation] A critical role for the multifunctionality of anti-tumor human T cells in TCR gene therapy evaluated in an in vivo model utilizing NOG mice2009
- Author(s)
  Mizuno Y, Ikeda H, Shirakura Y, Hiasa A, Hyuga C, Wang L, Imai N, Sato E, Ito M, Yu S, Mineno J, Kato I, Shiku H
- Organizer
  CRI symposium 2009
- Place of Presentation
  NY, USA
- Data Source
  KAKENHI-PROJECT-21591664
[Presentation] GITRL-Fc分泌型融合蛋白の腫瘍内発現による腫瘍抗原特異的T細胞の活性化機構2009
- Author(s)
  池田裕明、三井潤、峰野純一、加藤郁之進、珠玖洋
- Organizer
  第13回日本がん免疫学会総会
- Place of Presentation
  小倉
- Data Source
  KAKENHI-PROJECT-21591664
[Presentation] Adoptive immunotherapy for cancer with genetically engineered T cells「遺伝子改変T細胞移入療法」2009
- Author(s)
  Ikeda H, Okamoto S, Mineno J, Imai N, Ito M, Yasukawa M, Takesako K, Shiku H
- Organizer
  第71回日本血液学会学術集会
- Place of Presentation
  京都
- Data Source
  KAKENHI-PROJECT-21591664
[Presentation] critical role for CD4^+ T cells in the induction of multifunctionality of tumor-specific CD8^+ T cells. 「CD4^+ T細胞は腫瘍特異的CD8^+ T細胞のマルチファンクション性獲得に重要な役割を果たす」2009
- Author(s)
  Imai N, Ikeda H, Tawara I, Mori K, Yamane M, Wang L, Shiku H
- Organizer
  第39回日本免疫学会総会・学術集会
- Place of Presentation
  大阪
- Data Source
  KAKENHI-PROJECT-21591664
[Presentation] Specific silencing of endogenous TCR with siRNAs in human lymphocytes improved expression and anti-tumor reactivity of transduced tumor-specific TCRs2009
- Author(s)
  Okamoto S, Mineno J, Ikeda H, Fujiwara H, Yasukawa M, Shiku H, Kato I
- Organizer
  Internationaal Society for Biological Therapy of Cancer (iSBTc) 2009 annual meeting
- Place of Presentation
  米国、ワシントンDC
- Data Source
  KAKENHI-PROJECT-21591664
[Presentation] Improved expression and anti-tumor reactivity of transduced tumor-specific TCRs in human lymphocytes by specific silencing of endogenous TCR2009
- Author(s)
  Okamoto S, Mineno J, Ikeda H, Fujiwara H, Yasukawa M, Shiku H, Kato I
- Organizer
  CRI symposium 2009
- Place of Presentation
  NY, USA
- Data Source
  KAKENHI-PROJECT-21591664
[Presentation] Multistage activation of tumor-specific CD8^+ T cells by intratumor secretion of GITRL-Fc「GITRL-Fc分泌型融合蛋白の腫瘍内発現による腫瘍特異的T細胞の多層的活性化機構」2009
- Author(s)
  Mitsui J, Ikeda H, Hosoi H, Mineno J, KatoI, Kondo S, Shiku H
- Organizer
  第68回日本癌学会学術総会
- Place of Presentation
  横浜
- Data Source
  KAKENHI-PROJECT-21591664
[Presentation] GITR stimulation enhances anti-tumor effect of adoptive cell therapy with antigen-specific CD8^+ T cells2007
- Author(s)
  Nishikawa, N, Imai, N, Ikeda, H, Kato, T, Tawara, I, Mod, K, Wang, L, Shiku, H
- Organizer
  66th, Annual meeting of JCA
- Place of Presentation
  Yokohama
- Year and Date
  2007-10-05
- Description
  「研究成果報告書概要(欧文)」より
- Data Source
  KAKENHI-PROJECT-18591534
[Presentation] GITR stimulation enhances anti-tumor effect of adoptive cell therapy restoring activation of antigen-specific CD8^+ T cells2007
- Author(s)
  Imai N, Ikeda H, Nishikawa H, Yamashita Y, Tawara I, Kato T Shiku H.
- Organizer
  Cancer Research Institute, International Cancer Immunotherapy Symposia Series
- Place of Presentation
  米国ニューヨーク
- Year and Date
  2007-10-04
- Description
  「研究成果報告書概要(和文)」より
- Data Source
  KAKENHI-PROJECT-18591534
[Presentation] GITR stimulation enhances anti-tumor effect of adoptive cell therapy restoring activation of antigen-specific CD8^+ T cells2007
- Author(s)
  Ikeda, H, Imai, N, Nishikawa, N, Kato, T, Tawara, I, Mori, K, Wang, L, Shiku, H
- Organizer
  37th Annual Meeting of JSI
- Place of Presentation
  Tokyo
- Year and Date
  2007-11-22
- Description
  「研究成果報告書概要(欧文)」より
- Data Source
  KAKENHI-PROJECT-18591534
[Presentation] GITR stimulation enhances anti-tumor effect of adoptive cell therapy restoring activation of antigen-specific CD8^+ T cells2007
- Author(s)
  Ikeda H, Imai N, Nishikawa N, Kato T, Tawara I, Mori K, Wang L, Shiku H.
- Organizer
  第37回日本免疫学会総会・学術集会
- Place of Presentation
  東京
- Year and Date
  2007-11-22
- Description
  「研究成果報告書概要(和文)」より
- Data Source
  KAKENHI-PROJECT-18591534
[Presentation] A clinical trial of CHP-HER2 vaccine with adjuvant GM-CSF: A case representing antigen spreading2007
- Author(s)
  Kitano S, Kageyama S, Nishikawa H, Hirayama M, Hiasa A, Ikeda, H, Old, LJ, Shiku H.
- Organizer
  Cancer Research Institute, International Cancer Immunotherapy Symposia Series
- Place of Presentation
  米国ニューヨーク
- Year and Date
  2007-10-04
- Description
  「研究成果報告書概要(和文)」より
- Data Source
  KAKENHI-PROJECT-18591534
[Presentation] A clinical trial of CHIP-HER2 vaccine with adjuvant GM-CSF : A case representing antigen spreading2007
- Author(s)
  Kitano, S, Kageyama, S, Nishikawa, H, Hirayama, M, Hiasa, A, Ikeda, H, Old, IJ, Shiku, H
- Organizer
  Cancer Research Institute, International Cancer Immunotherapy Symposia Series
- Place of Presentation
  NY
- Year and Date
  2007-10-04
- Description
  「研究成果報告書概要(欧文)」より
- Data Source
  KAKENHI-PROJECT-18591534
[Presentation] GITR stimulation enhances antitumor effect of adoptive cell therapy restoring activation of antigenspecific CD8+ T cells2007
- Author(s)
  Ikeda H, Imai N, Nishikawa N, Kato T, Tawara I, Mori K, Wa ngL, Shiku H.
- Organizer
  第37回日本免疫学会総会・学術集会
- Place of Presentation
  東京
- Year and Date
  2007-11-22
- Data Source
  KAKENHI-PROJECT-18591534
[Presentation] Mechanism of GITR-mediated enhancement of adoptive cell therapy of tumor-specific CD8^+ T cells2007
- Author(s)
  Imai, N, Ikeda, H, Nishikawa, H, Kato, T, Tawara, I, Mod, K, Wang, L, Shiku, H
- Organizer
  11th Annual Meeting of SFCI
- Place of Presentation
  Tokyo
- Year and Date
  2007-07-12
- Description
  「研究成果報告書概要(欧文)」より
- Data Source
  KAKENHI-PROJECT-18591534
[Presentation] GITR stimulation enhances anti-tumor effect of adoptive cell therapy with antigen-specific CD8+ T cells2007
- Author(s)
  Nishikawa N, Imai N, Ikeda H, Kato T, Tawara I, Mori K, Wang L, Shiku H.
- Organizer
  第66回日本癌学会学術総会
- Place of Presentation
  横浜
- Year and Date
  2007-10-05
- Data Source
  KAKENHI-PROJECT-18591534
[Presentation] 腫瘍特異的CD8^+T細胞移入療法のGITR刺激による効果増強機序の解析2007
- Author(s)
  今井奈緒子、池田裕明、西川博嘉、加藤琢磨、俵功、森和子、王立楠、珠玖洋
- Organizer
  第11回基盤的癌免疫研究会総会
- Place of Presentation
  東京
- Year and Date
  2007-07-12
- Description
  「研究成果報告書概要(和文)」より
- Data Source
  KAKENHI-PROJECT-18591534
[Presentation] GITR stimulation enhances antitumor effect of adoptive cell therapy restoring activation of antigen・specfic CD8+ T cells2007
- Author(s)
  Imai N, Ikeda H, Nishikawa H, Yamashita Y, Tawara I, Kato T, Shiku H.
- Organizer
  Cancer Research Institute, International Cancer Immunotherapy Symposia Series
- Place of Presentation
  米国ニューヨーク
- Year and Date
  2007-10-04
- Data Source
  KAKENHI-PROJECT-18591534
[Presentation] GITR stimulation enhances anti-tumor effect of adoptive cell therapy with antigen-specific CD8^+ T cells2007
- Author(s)
  Nishikawa N, Imai N, Ikeda H, Kato T, Tawara I, Mori K, Wang L, Shiku H.
- Organizer
  第66回日本癌学会学術総会
- Place of Presentation
  横浜
- Year and Date
  2007-10-05
- Description
  「研究成果報告書概要(和文)」より
- Data Source
  KAKENHI-PROJECT-18591534
[Presentation] 腫瘍特異的CD8+T細胞移入療法のGITR刺激による効果増強機序の解析2007
- Author(s)
  今井奈緒子、池田裕明、西川博嘉、加藤琢磨、俵功、森和子、王立楠、珠玖洋
- Organizer
  第11回基盤的癌免疫研究会総会
- Place of Presentation
  東京
- Year and Date
  2007-07-12
- Data Source
  KAKENHI-PROJECT-18591534
[Presentation] A clinical trial of CHP・HER2 vaccine with adjuvant GM-CSF: A case representing antigen spreading2007
- Author(s)
  Kitano S, Kageyama S, Nishikawa H, Hirayama M, Hiasa A, Ikeda, H, Old, LJ, Shiku H.
- Organizer
  Cancer Research Institute, International Cancer Immunotherapy Symposia Series
- Place of Presentation
  米国ニューヨーク
- Year and Date
  2007-10-04
- Data Source
  KAKENHI-PROJECT-18591534
[Presentation] stimulation enhances anti-tumor effect of adoptive cell therapy restoring activation of antigen-specific CDS^+ T cells2007
- Author(s)
  Imai, N, Ikeda, H, Nishikawa, H, Yamashita, Y, Tawara, I, Kato, T, Shiku, H. GITR
- Organizer
  Cancer Research Institute, International Cancer Immunotherapy Symposia Series
- Place of Presentation
  NY
- Year and Date
  2007-10-04
- Description
  「研究成果報告書概要(欧文)」より
- Data Source
  KAKENHI-PROJECT-18591534
[Presentation] Identification of new helper epitope of NY-ESO-1 and MAGE-A4 for efficient Th1 cell therapy2006
- Author(s)
  Tsuji, K, Ohkuri, T, Abe, H, Sato, M, Ikeda, H, Matsubara, N, Togashi, Y, Kitamura, H, Nishimura, T
- Organizer
  65th, Annual Meeting of JCA
- Place of Presentation
  Yokohama
- Year and Date
  2006-09-29
- Description
  「研究成果報告書概要(欧文)」より
- Data Source
  KAKENHI-PROJECT-18591534
[Presentation] Th1細胞治療に有用なNY-ESO-1及びMAGE-A4特異的Th細胞の誘導と新規ヘルパーエピトープの同定2006
- Author(s)
  辻景子, 大栗敬幸, 阿部洋行, 佐藤政芳, 池田裕明, 松原直紀, 富樫裕二, 北村秀光, 西村孝司
- Organizer
  第65回日本癌学会総会
- Place of Presentation
  横浜
- Year and Date
  2006-09-29
- Description
  「研究成果報告書概要(和文)」より
- Data Source
  KAKENHI-PROJECT-18591534
[Presentation] T細胞免疫反応と免疫記憶Homeostatic Prolferationで誘導されるEm、Cmの性状解析と自己免疫病との関連性2006
- Author(s)
  野口大輔, 脇田大功, 小坂朱, 成田義規, 大西英晃, 松原直紀, 北村秀光, 池田裕明, 西村孝司
- Organizer
  第36回本免疫学会総会・学術集会
- Place of Presentation
  大阪
- Year and Date
  2006-12-11
- Description
  「研究成果報告書概要(和文)」より
- Data Source
  KAKENHI-PROJECT-18591534
[Presentation] Identification of new helper epitope of NY-ESO-1 and MAGE-A4 by induction of specific helper T cells2006
- Author(s)
  Ohkuri, T, Tsuji, K, Abe, H, Sato, M, Yamagishi, Y, Ikeda, H, Matsubara, N, Togashi, Y, Kitamura, H, Nishimura, T
- Organizer
  10th Annual Meeting of SFCI
- Place of Presentation
  Sapporo
- Year and Date
  2006-07-14
- Description
  「研究成果報告書概要(欧文)」より
- Data Source
  KAKENHI-PROJECT-18591534
[Presentation] NY-ESO-1および,MAGE-A4特異的Th細胞の誘導と,新規ヘルパーエピトープの同定2006
- Author(s)
  大栗敬幸, 辻景子, 阿部洋行, 佐藤政芳, 山岸結香, 池田裕明, 松原直紀, 冨樫裕二, 北村秀光, 西村孝司
- Organizer
  第10回基盤的癌免疫研究会総会
- Place of Presentation
  札幌
- Year and Date
  2006-07-14
- Description
  「研究成果報告書概要(和文)」より
- Data Source
  KAKENHI-PROJECT-18591534
[Presentation] Analysis of Em and Cm cells induced by homeostatic proliferation and its relationship to autoimmune disease2006
- Author(s)
  Noguchi, D, Wakita, D, Kosaka, A, Narita, Y, Ohnishi, H, Matsubara, N, Kitamura, H, Ikeda, H, Nishimura, T
- Organizer
  36th Annual Meeting of JSI
- Place of Presentation
  Osaka
- Year and Date
  2006-12-11
- Description
  「研究成果報告書概要(欧文)」より
- Data Source
  KAKENHI-PROJECT-18591534
[Presentation] Clinical application of TCR gene-transduced lymphocytes for patients with epitherial cancer or leukemia.
- Author(s)
  Hiroaki Ikeda
- Organizer
  17th Us-Japan Cellular and Gene Therapy Conference
- Place of Presentation
  Bethesta, USA
- Invited
- Data Source
  KAKENHI-PROJECT-24390300

1. Yasui Kiyoshi (50372777)

# of Collaborated Projects: 4 results

# of Collaborated Products: 13 results
2. MIYAMOTO Masaki (40333611)

# of Collaborated Projects: 3 results

# of Collaborated Products: 5 results
3. MORIKAWA Toshiaki (60292025)

# of Collaborated Projects: 2 results

# of Collaborated Products: 0 results
4. KONDO Satoshi (30215454)

# of Collaborated Projects: 2 results

# of Collaborated Products: 5 results
5. NISHIMURA Takashi (30143001)

# of Collaborated Projects: 2 results

# of Collaborated Products: 24 results
6. Muraoka Daisuke (20608955)

# of Collaborated Projects: 2 results

# of Collaborated Products: 5 results
7. NISHIKAWA Hiroyoshi (10444431)

# of Collaborated Projects: 1 results

# of Collaborated Products: 6 results
8. AKITA Hirotoshi (70222528)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
9. TAWARA Isao (80378380)

# of Collaborated Projects: 1 results

# of Collaborated Products: 3 results
10. TAKATSUKI Mitsuhisa (80380939)

# of Collaborated Projects: 1 results

# of Collaborated Products: 1 results
11. 浅井章良 (60381737)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
12. 丸屋安広 (20817085)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
13. 東美樹 (40814504)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
14. 金高賢悟 (10549570)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
15. 松下博和 (80597782)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
16. 米田光宏 (80508367)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
17. 金子雅幸 (10322827)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
18. 齋藤敦 (30580394)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
19. KUBO Yoshinao

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results
20. NAGATA Yasuhiro

# of Collaborated Projects: 0 results

# of Collaborated Products: 2 results
21. MASUYA Masahiro

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results
22. 影山慎一

# of Collaborated Projects: 0 results

# of Collaborated Products: 3 results
23. 林日出喜

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results
24. 小笠原康悦

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results
25. 赤塚美樹

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results
26. 曽我倫久人

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results
27. 夏目敦至

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results
28. 加藤琢磨

# of Collaborated Projects: 0 results

# of Collaborated Products: 2 results
29. 宮原慶裕

# of Collaborated Projects: 0 results

# of Collaborated Products: 2 results
30. 安川正貴

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results

IKEDA Hiroaki 池田 裕明

Research Projects

Research Products

Co-Researchers

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

T cell therapy that overcome tumor heterogeneity by expansion of T cell repertoire and immune-related cell death effect.Principal Investigator

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

バイスタンダー効果を増強する新規化合物による腫瘍不均一性を克服するがん免疫療法Principal Investigator

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Development of immune cell therapy of refractory tumor utilizing allogeneic designer cellsPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Personalized cancer immunotherapy of gastrointestinal tumors based on identification of neoantigens and reverting of immunosuppressionPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Development of cell therapy for patients with tumors utilizing allogeneic stealth T cellsPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Principal Investigator

IKEDA Hiroaki 池田裕明